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Abstract
Binding reactions can be ideally investigated by Dual-Color Fluorescence Cross-
Correlation Spectroscopy (FCCS). Here, this method is used to study the recruit-
ment and dissociation of proteins to and from the spliceosome. The spliceosome is
the cellular machinery responsible for removing non-coding introns from precursor
mRNA (pre-mRNA).
The spliceosome assembles on a pre-mRNA, which consists of two exons and one
intron, stepwise by the binding of ve snRNPs and several other proteins. This
leads to the formation of the B complex which has no active catalytic center yet.
Structural rearrangements lead to the activated Bact complex which is formed by
further rearrangements in the catalytically active B* complex. The B* complex
catalyzes the rst splicing step in which the branch site (BS) attacks the 5' splice
site (5'SS). The 5' exon is cleaved and the intron-3'-exon lariat is formed. The re-
sulting C complex then catalyzes the second splicing step. The intron is cleaved and
both exons are joined together forming mature mRNA. During both catalytic steps,
the spliceosome undergoes many changes in its protein composition, and several
structural rearrangements occur.
These changes and rearrangements can be investigated by standard biochemical
methods. However, these methods often do not provide data about dynamics, which
are necessary for understanding the recruitment and release of particular molecules.
One method which provides these information is FCCS. In contrast to methods
like mass spectrometry, in FCCS measurements it is possible to observe reactions in
real-time and at equilibrium without further biochemical perturbation of the sample.
FCCS works at low nanomolar concentrations and only small sample volumes are
necessary. Using FCCS, it could be determined how changes in the spliceosome
composition and conformation occur (simultaneously or consecutively). The roles
of certain spliceosomal RNA helicases in the restructuring of the complex could be
investigated. FCCS enables the observation of protein-protein interactions and the
determination of binding constants for proteins to the spliceosome.
In order to better understand the dynamic nature of the spliceosome during its cat-
alytic activation, the step 1 factor Cwc25 and the step 2 factors Slu7, Prp18, and
Prp16 were investigated. Their role in the maturation process, the fundamental
question of the time point and manner of their recruitment has not been answered
yet.
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With FCCS, the binding of the step 1 factor Cwc25 was observed. It was shown
that Cwc25 has a high-binding anity to the spliceosome after the Prp2-mediated
rearrangements into the catalytically activated B* complex. The high-binding an-
ity was reected in a strong binding constant of 30 pM which was measured with
FCCS.
By using several mutant pre-mRNAs it could be demonstrated that Cwc25's release
does not depend on the second catalytic step per se. Its dissociation depends on the
docking of the 3'SS to the active site and the action of Prp16 and Slu7/Prp18. It
was also observed that the distance between the branch site and 3'SS inuences the
release of Cwc25 and the second catalytic step. If the distance between BS and 3'SS
is short (e.g. 7 nucleotides long), the distance between the 3'SS and the active site is
also small. The 3'SS can dock into the active site without the further stabilization
by Slu7/Prp18. The activity of Prp16 and the docking event lead to the release
of Cwc25. Slu7/Prp18 can stabilize the system and thereby induce further release
of Cwc25. If the distance between BS and 3'SS is longer (e.g. 38 nucleotides),
Slu7/Prp18 has to stabilize the interaction of the 3'SS and the active site and the
step 2 conformation. In this case, Prp16 alone cannot induce the release of Cwc25.
Cwc25 does dissociate from the spliceosome after the action of Prp16 and in the
presence of Slu7/Prp18.
It was shown further that Prp16 and its ATPase activity are necessary for the
formation of a functional step 2 active site. Slu7/Prp18 are required for the ecient
docking of the 3' splice site (3'SS) to the active site. The FCCS experiments showed
that Prp16 and Slu7/Prp18 have distinct binding sites in the spliceosome which
are formed during the catalytic activation. During activation their rst low-anity
binding sites are transformed into high-anity binding sites. Both proteins are
bound to the spliceosome at an early stage so that they are present before their
catalytic function is actually required in the process.
Here, it was shown that FCCS is ideally suited to investigate macromolecular protein
complexes like the spliceosome and is a powerful tool for studying quantitatively
spliceosomal protein dynamics at equilibrium.
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1 Introduction
Many biochemical methods which are used to study macromolecular complexes, e.g.
the spliceosome or ribosome, provide only semi-quantitative results. They yield only
little information about dynamics, which are necessary for understanding the bind-
ing behavior between proteins and proteins or proteins and complexes. A method
that provides data about dynamics in real-time is Dual-Color Fluorescence Cross-
Correlation Spectroscopy (FCCS). This method is an ideal tool to quantitatively
study the protein dynamics of the spliceosome.
1.1 Fluorescence Cross-Correlation Spectroscopy
FCCS is an extension of Fluorescence Correlation Spectroscopy (FCS). FCS was
introduced in the 1970s by Magde et al. [1] [2] [3]. It allows for the observation of
e.g. photophysical dynamics of uorescent molecules [4] [5] [6], conformational dynam-
ics [7] [8], interactions of macromolecules [9], and biochemical kinetics [10] [11]. FCS re-
quires single molecule sensitivity for these observations. The technique is applicable
to freely diusing, uorescently labeled molecules in solution. The uorescence uc-
tuations of a signal arising from molecules diusing through the confocal volume
are analyzed with statistical methods. By calculating a temporal auto-correlation
of the signal, diusion coecients and concentrations of the uorescently labeled
molecules can be determined [12]. Information about binding reactions between dif-
ferent molecules are less accessible with FCS. There are dierent reasons why FCS
is not useful for monitoring binding reactions:
First of all, the diusion coecient depends only weakly on the molecular weight.
According to the well known Stokes-Einstein equation, the diusion coecient is
inversely proportional to the hydrodynamic radius [13]. The hydrodynamic radius in
turn depends on the cubic root of the molecular weight. Small changes in the molec-
ular weight will thus barely inuence the molecule's diusion coecient. Binding
reactions, which are only accompanied by such small changes in molecular weight,
can therefore hardly be observed in FCS measurements [14]. Additionally, aggregates
can distort the correlation curves, which further complicates the analysis.
Another problem in applying FCS in binding studies is the confocal detection vol-
ume. The size and shape of the detection volume depend on the laser intensity and
are sensitive against refractive index mismatch between the sample and the objec-
tive's immersion medium. The diusion coecient in turn depends on the shape
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and size of the detection volume. The resulting distortions introduce errors in an
FCS experiment for binding studies [14].
Additionally, FCS is severely aected by variations in the molecular brightness
(counts per second per molecule) of a uorophore. The molecular brightness is
strongly inuenced if two uorescently labeled molecules are bound to each other.
Statistical labeling of multiple sites in one molecule also leads to a broad distribution
in the molecular brightness [14]. Both of these contributions introduce errors during
FCS evaluation.
These limitations can be overcome by FCCS, which is based on FCS and retains
the high sensitivity of that method. The main dierence between both methods
is the use of two excitation lasers at two dierent wavelengths in FCCS instead of
one laser at one wavelength in FCS. In FCCS, the spontaneous uorescence uctua-
tions of two molecules labeled with dierent uorescent dyes are detected separately
and compared to each other. This is done by a cross-correlation analysis [15], which
provides information about the binding behavior of the two uorescently labeled
species. If the molecules are not bound, the uorescence signals are uncorrelated. If
the molecules are bound to each other, there is a correlation between the uorescence
signals. This correlation yields a cross-correlation curve with an amplitude which is
higher than that of an FCCS measurement on a sample with unbound molecules [16].
The amplitude is directly proportional to the fraction of bound molecules.
Figure 1: If the two uorescently labeled molecules are not bound to each other, the cross-
correlation amplitude is small. If the molecules are bound, the cross-correlation amplitude
is large.
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In contrast to many biochemical and physical methods, FCCS has several advan-
tages, e.g it yields quantitative information about dynamics of recruitments and
dissociations. In particular, FCCS is a useful method for determining protein and
RNA interactions because it works at nanomolar concentrations and low sample vol-
umes are necessary. Additionally, it can be applied at equilibrium without further
biochemical perturbation of the sample and investigation of reactions in real-time
are possible [12] [10] [17].
1.1.1 Applications of FCCS
The rst theoretical concept of FCCS was developed by Eigen et al. [18]. The rst ex-
periments with FCCS were done by Schwille et al. [19], who used the cross-correlation
between two uorescent signals to observe the hybridization kinetics of two oligonu-
cleotides labeled with dierent uorophores. For the experimental realization, they
used a confocal setup with two lasers. The laser beams were focused on the same
spot. By using two spectrally resolved detectors, the uorescence signals could be
detected in a wavelength-sensitive way [19].
In the next approach, Rigler et al. used FCCS to detect amplied DNA sequences
in a polymerase chain reaction. They monitored the formation of double-stranded
DNA with two uorescently labeled primers [20]. The doubly labeled DNA strands
were further used in the study of Kettling et al. [10], where a DNA substrate was
uorescently labeled with two dyes at opposite ends and the enzymatic cleavage of
the DNA by an endonuclease was monitored. They could quantify the enzymatic
activity by measuring reaction rates.
In addition to DNA-DNA interactions, protein-protein interactions have been ob-
served. Bieschke et al. used FCCS to monitor prion-protein aggregations [21]. In
the study of Varghese et al., FCCS was used to investigate the diusion behavior,
binding kinetics, and eect of small organic molecules on the binding of IgG and
Fab fragments of anti-IgG molecules [22]. This work demonstrated the usefulness of
FCCS for kinetic studies on freely diusing molecules in solution.
Further quantitative investigation of ligand binding was developed by Weidemann
et al. They took into account the focal geometry, background signal, and cross-talk
as well as photophysical and biochemical eects [23]. These parameters can inuence
the brightness of the uorophores and thereby the uorescence signals which were
used for analysis. A practical guideline for FCCS measurements which considered
the limitations and corrections of these experiments was published by Bacia et al. [24].
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Several further studies dealt with the limitations and theoretical foundations of
FCCS. FCCSs main intrinsic problem is cross-talk. Cross-talk results from cross-
excitation and cross-emission. In the case of cross-excitation, the dye with the higher
wavelength is excited by the laser with the shorter wavelength. Cross-emission re-
sults from the coupling of the uorescence signal of the dye with the shorter excita-
tion wavelength into the detection channel for the longer wavelength. Corrections
for cross-talk and quenching have been given in the work of Földes-Papp [15]. He also
provided a theoretical overview about FCCS. Crosstalk in FCCS can be experimen-
tally avoided by using appropriate excitation and emission lters.
Instead of exciting the sample with a continuous wave laser like in the work of
Schwille [19], two alternatingly pulsed lasers can be used [25]. This results in suppress-
ing cross-talk by using the uorescence lifetimes of the uorophores. The uores-
cence lifetime is the average time of a molecule in the excited state before emitting
a photon and returning into the ground state. The conventional way to measure
uorescence lifetimes is Time-Correlated Single-Photon Counting (TCSPC). In a
TCSPC experiment, the sample is excited with a pulsed laser. Single uorescence
photons are then detected and their arrival times in relation to the excitation pulse
are measured. Finally, the photons are sorted according to their arrival times in
a histogram. This histogram reects the exponential decay of the uorescence in-
tensity and allows for the determination of the uorescence lifetime. By measuring
the uorescence lifetimes of two dierent uorophores, it is possible to distinguish
between the uorescence photons of both dyes and reduce cross-talk. Thews et al.
used this method to investigate the binding behavior of proteins in live cells [25]. Be-
side this work, a lot of FCCS studies were performed on cells [26] [27] [28]. By applying
FCCS on and in cells, studies on many dierent parts of living cells are possible.
Weidemann et al. for example investigated the ligand-receptor interactions in the
plasma membrane [14].
A limitation in FCCS measurements is that the two detection volumes have to
overlap to excite the two dierent uorophores simultaneously. To achieve this ex-
perimental, the two lasers have to be aligned to the same spot. The diculty of
alignment can be avoided by using Single-Wavelength FCCS (SW-FCCS). In this
method, two dierent uorophores are used which are excitable with the same wave-
length but have dierent emission wavelengths. Therefore, the dierence between
the maximum in the absorption spectra and the maximum in the emission spectra,
the so-called Stokes shift, diers for both uorophores. The uorescence signals
are detected in two spectrally distinct detection channels [29,30]. The advantage of
1. Introduction 7
SW-FCCS is the easier alignment of only one laser beam instead of two. The disad-
vantage of this method is higher cross-talk, which cannot be suppressed completely.
Another approach for avoiding non-ideally overlapping detection volumes is the com-
bination of FCCS with two-photon excitation. In the work of Heinze et al., a two-
photon laser was used to excite two uorophores with the same excitation wave-
length but dierent emission wavelengths [31,32]. During the excitation, two photons
are simultaneously absorbed by a uorophore, exciting the molecule into a higher
electronic state. The sum of the energy of both photons has to correspond to the
energy which is necessary to excite the molecule [16]. The excitation spectra of a
uorophore of two-photon excitation can dier from the spectra upon one-photon
excitation, whereas the emission will be the same. FCCS experiments with two-
photon excitation were shown for two dierent uorophores, i.e. Rhodamin green
and Texas red, which can be excited simultaneously but showed dierent emission
spectra [31]. Similar to SW-FCCS, the exact alignment of two laser beams is not
necessary. Finding suitable uorescent dyes, however, can be a problem.
In this work FCCS was used to investigate recruitment and dissociation orders of
proteins in the yeast spliceosome. The suitability of FCCS for measuring binding
constants of a small protein to a large macromolecular complex is tested. Changes
in the binding strength of proteins in a complex system are observed and a further
application is the determination of protein composition.
1.1.2 Alternative methods for monitoring protein interactions
Another and widely used method to determine the protein composition of a biological
sample is Mass Spectrometry (MS). With this method, a multiprotein complex, e.g.
the nuclear pore complex or the spliceosome, can be investigated. For a mass spec-
trometry measurement, the biological sample rst has to be ionized and transferred
into the gas phase. One method for the ionization step is Matrix-Assisted Laser
Desorption Ionization (MALDI). This is a non-destructive ionization and vaporiza-
tion method in which biomolecules are imbedded in a solid matrix. By irradiating
the matrix with a UV laser pulse in the presence of a high-voltage electric eld,
the biomolecules are ionized and accelerated. After their acceleration, the mass-to-
charge ratio of the ionized biomolecules is analyzed with e.g. a time-of-ight (TOF)
analyzer. TOF analysis is based on comparing the kinetic energies of the respec-
tive molecules. After acceleration, all molecules have the same kinetic energy. The
kinetic energy depends on the mass and velocity of the molecule, i.e. molecules of
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the same kinetic energy but dierent molecular weight will have dierent velocities.
The TOF analyzer measures the dierences in velocities of the ionized biomolecules.
In most cases, electron multipliers are used for detection [16]. In the end, the re-
sults of the mass spectrometry measurements are compared to values from a protein
database. Thereby, the components of a complex biological sample can be identied.
In many biological complexes, e.g. the spliceosome, the ordered recruitment and
subsequent release of certain proteins is important. Mass spectrometry is a sensitive
method, which gives good indications about the relative amount of a protein in a
complex system, i.e. the spliceosome. However, only semi-quantitative information
about dynamics induced by certain proteins and their binding and release are pro-
vided. To gain more information, complex further purication steps are necessary.
These can be avoided by using FCCS which enables measurements in real-time and
at equilibrium without further biochemical purication.
Another method for monitoring protein-protein interactions is Fluorescence Anisotropy
(FA). This method is based on the polarization of a uorescence signal. During an
FA measurement, a uorophore attached to a molecule is excited using linearly po-
larized light. The intensity of the uorescence emission is then measured through a
polarizer. By changing the orientation of the polarizer, the intensities with polar-
izations parallel and perpendicular to the excitation polarization can be measured.
The anisotropy describes the degree of polarization of a sample.
Most uorophores absorb light in a preferred direction, namely parallel to the ab-
sorption transition moment of the uorophore. For absorption, the electric dipole
of a uorophore does not need to be aligned exactly with the axis, among which
the excitation light is polarized. The probability of absorption is proportional to
cos2(Θ) with the angle Θ between the absorption dipole and the axis. Due to Brow-
nian motion a molecule starts to rotate. Observing the emission intensities with
polarization parallel and perpendicular to the excitation polarization over time al-
lows for measuring changes in the intensities due to the rotational movement of the
molecule. The excited molecule will be randomized and the anisotropy will decay.
The dependance of the anisotropy on the time is measured by the time-resolved
anisotropy. This is an exponential decay with a characteristic time constant, i.e.
the rotational correlation time. This factor depends on the viscosity and temper-
ature of the surrounding medium, and the volume of the rotating molecule. It is
also related to the rotational diusion coecient. Binding interactions between dif-
ferent molecules can change the rotational diusion coecient of the molecules and
thereby the anisotropy.
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Fluorescence Anisotropy has several limitations. First, the uorescence lifetime of
the uorophore has to be similar to the rotational correlation time. If the lifetime
is shorter than the rotational correlation time, the uorescence light is emitted be-
fore the molecule rotates completely. In this case, FA is not suitable for observing
binding reactions between molecules. Second, the local motion of the uorophore
which is attached via a linker to the molecule of interest can inuence the anisotropy.
Segmental motion of the linker between the uorophore and the molecule without
motion of the macromolecule itself contributes to a depolarization of the sample
and can inuence the observation of binding reactions. Application of Fluorescence
Anisotropy on a macromolecular complex can be challenging.
In this work, which was a cooperation with the group of Prof. Lührmann from the
MPI for biophysical chemistry, FCCS was used to study the spliceosome. While the
biological part (sample preparation and biochemical characterization of the samples)
was done in the Lührmann lab, the spectroscopy part including the entire data
analysis and evaluation was done by myself.
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1.2 The spliceosome
1.2.1 From genes to proteins
The whole genetic information of higher organisms is encoded in their genome in
form of DNA. The DNA sequence contains the information for the assembly and
function of proteins. The information transfer from genes to proteins proceeds over
dierent steps and with the help of a lot of macromolecular complexes, e.g. the
spliceosome and ribosome (see g. 2).
Figure 2: An overview of information ow from genes to proteins. The DNA is
transcribed into pre-mRNA. The pre-mRNA is processed into mRNA by the spliceosome.
The mRNA is transported out of the nucleus into the cytoplasm via a nuclear pore complex.
In the cytoplasm the mRNA is translated into polypeptides by ribosomes.
First, the DNA is transcribed into precursor-messenger RNA (pre-mRNA). Dur-
ing this process, one of two DNA strands is complementary copied into pre-mRNA
and the transcribed pre-mRNA contains the same information. Responsible for the
transcription is a complex enzyme, i.e. the RNA polymerase. In eukaryotes three
RNA polymerases exist: RNA polymerase I, II, and III, which transcribe dierent
RNAs.
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Next, the pre-mRNA has to be processed. The RNA processing includes dierent
steps. Two processes which occur during and immediately after transcription are
the modication of the 5' end and 3' end. At the 5' end a 5' cap is added. This is
a modied guanine nucleotide. To the 3' end, a poly(A) tail is linked. Both modi-
cations, capping of the 5' end and polyadenylation of the 3' end, are important for
the nuclear export, translation, and stability of mRNA. A third process has to be
performed because of the mosaic structure of eukaryotic genes which contains exons
and introns. The exons are segments of the sequence which are coding for the syn-
thesis of proteins. The introns are the non-coding segments. Genes with exons and
introns are widespread among eukaryotes. The introns of simpler eukaryotes (e.g.
yeast) are smaller in number and in size than those of plants or animals. Because
the introns do not contribute to the later protein synthesis, they have to be removed.
This is done by a process called splicing. During splicing, the pre-mRNA strand is
cut at both ends of the intron and the exons are covalently joined. Thereby, the
pre-mRNA is converted into mRNA, which contains only the exons [33,34].
Transcription and RNA processing proceed in the cell nucleus, whereas protein syn-
thesis occur in the cytoplasm. Thus, in the next step the mRNA has to be trans-
ported out of the cell nucleus through the nuclear pore complex into the cytoplasm.
There, the translation of the mRNA into a polypeptide chain by the ribosome oc-
curs. Ribosomes are complex ribonucleoprotein machines consisting of ribosomal
RNA and ribosomal proteins [33,34].
Overall, splicing is an important step in gene expression because precise splicing of
pre-mRNA is essential for synthesis of functional proteins [34].
1.2.2 pre-mRNA splicing
The spliceosome cleaves the introns in a very precise reaction out of the pre-mRNA.
This is possible by conserved sequences within the exon and intron. Studies on
many eukaryotic systems showed three conserved consensus sequences: the 5' Splice
Site (5'SS), the 3' Splice Site (3'SS), and the Branch Site (BS). The 5'SS is located
at the 5' end of an intron and the 3'SS at the 3' end of an intron. The BS is located
between 10 to 155 nucleotides upstream of the 3'SS. All three elements are highly
conserved in S.cerevisiae [35,36] and the conserved sequences at the exon-intron border
of yeast and humans are shown in gure 3.
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Figure 3: Schematic representation of conserved sequences in introns of
S. cerevisiae and homo sapiens. The branch site (BS) adenosine is highlighted. Bold
letters indicate a 90 % or higher conservation of the respective nucleotide. Y stands for
pyrimidines, R for purines, N for a G or GX and X for A or G or U or C. (Yn) denotes
the polypyrimidine tract and the numbers indicate the distance between the 5'SS and the
BS and between the BS and the 3'SS. (Figure also appeared in the PhD thesis of Peter
Odenwälder)
In nature, two dierent types of splicing occur: self-splicing and splicing by the
spliceosome. In the process of self-splicing, RNAs can remove their introns without
the help of proteins. For non self-splicing introns, the spliceosome, which is a ri-
bonucleoprotein complex, has to process the pre-mRNA splicing. [37].
The self-splicing introns are sorted into two groups. The group I introns are found
commonly in fungal and plant mitochondria, plant chloroplasts, and in nuclear RNA
of lower eukaryotes (e.g. Tetrahymena). The nucleotide sequences of group I introns
are variable, but all of them form a similar three-dimensional structure. Together
with several conserved nucleotides, the structure allows the group I introns for cat-
alyzing the removal of the intron by themselves. For group I introns, the splicing
reaction is started by binding of a G nucleotide to the intron sequence. This G
nucleotide is activated to form an attacking group which will break the 5'SS [34,38].
Group II self-splicing introns are found in the pre-mRNA of fungal and yeast mi-
tochondria, and plant chloroplasts. In the self-splicing process of group II introns,
the 5' splice site is cleaved rst. Then the 5'SS is covalently bound to an adenosine
residue near the 3'SS of the intron and a structure called lariat is formed. Here,
the A nucleotide in the intron sequence is the attacking group. In the last step, the
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3'SS is cut, the intron is released, and the ends of the exons are bound covalently
together [34,38].
There are similarities between the group I and group II introns. For both groups
the sequence of the intron is important, because the intron is folded into a three-
dimensional structure which brings the ends of the intron in contact [34,38].
Figure 4: Principle of pre-mRNA splicing. The cleavage of the 5'SS and the forma-
tion of the lariat structure during the rst step are shown. In the second step, the 3'SS is
cleaved and the exons are ligated. (Adapted from Cooper [39].)
In contrast to the self-splicing introns, the introns of pre-mRNAs in animal cells
do not splice themselves. The steps are similar to the splicing of group II introns,
but a macromolecular complex, the spliceosome, is necessary to process the intron
removal. The spliceosome consists of a large number of proteins and ve ribonucle-
oparticles called snRNPs (small nuclear ribonucleoproteins). The snRNPs consist of
a small nuclear Ribonucleic Acid (snRNA), seven Sm proteins, and a variable num-
ber of specic proteins [40]. Because of their high amount of uracil, the spliceosome
snRNPs are denoted as the U1, U2, U4/U6, and U5 snRNP. The RNA molecules of
the snRNPs are relatively short with less than 200 nucleotides, but are involved in
the major part of pre-mRNA splicing.
The removal of an intron proceeds through two sequential phosphoryl-transfer re-
actions known as transesterications [41]. In the rst step, the adenosine of the BS
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attacks the 5'SS nucleophilically, generating the free 5' exon and the lariat-3'-exon
intermediates. In the second step, the 3' hydroxyl group of the 5' exon attacks the
3'SS. In the end, the exons are ligated and the intron lariat is released from the
complex [40] (see g. 4).
Pre-mRNAs can be spliced in dierent ways in a process called Alternative Splicing.
This occurs commonly in human cells and results in the generation of dierent
mRNAs from the same pre-mRNA. These lead to dierent polypeptide chains from
one gene. During alternative splicing, particular exons may be included within, or
excluded from, the pre-mRNA (see g. 5).
Figure 5: Scheme of the dierent modes of splicing: conventional splicing, exon
skipping, mutually exclusive exon splicing, alternative 5'SS splicing, alternative 3'SS splic-
ing, and intron retention.
In general, ve dierent modes of alternative splicing can be distinguished: In the
exon skipping case, an exon is spliced out or kept in the sequence. It is the most
common mode in mammalian pre-mRNAs [42]. In the case of mutually exclusive
exons, one exon is always kept in the mRNA, while a second one is always spliced
out. In the next case, dierent alternative 3'SS or 5'SS can be used. In the mode
of intron retention, a sequence can be spliced out as an intron or is retained [42].
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1.2.3 RNA processing by the spliceosome - the splice cycle
The spliceosome does not exist as a macromolecular complex before it processes
the pre-mRNA, but is assembled on the pre-mRNA in dierent steps. During these
steps, the snRNPS and multiple proteins bind to the pre-mRNA. After the assembly
of the spliceosome, the snRNPS and several splicing factors catalyze the removal of
the intron and the joining of the exons [34]. The process of splicing is done in a
stepwise manner and can be described with a splice cycle (see g 6).
The recognition of the 5'SS, 3'SS, and BS is done by base-pairing between the
snRNAs and the consensus sequences in the pre-mRNA. During the complete splic-
ing process, dierent base-pair interactions are broken and new interactions are
formed. The RNA sequences have to be checked multiple times before the chemical
reaction of base-pairing. The control mechanism increases the accuracy of splic-
ing [38].
During pre-mRNA splicing, the spliceosome hydrolyzes many ATPmolecules. While,
ATP hydrolysis is not required for the chemistry of splicing per se, the assembly
of the spliceosome and the rearrangements over the complete splicing process re-
quire ATP hydrolysis. Using the energy provided by ATP hydrolysis, the additional
proteins of the spliceosome rearrange RNA-RNA interactions. All RNA-RNA rear-
rangements which need ATP occur between the snRNPs themselves and between
snRNPS and the pre-mRNA. The remodeling steps in the yeast spliceosome are
driven by at least eight evolutionarily conserved DExH/D-box ATPases or RNA
helicases [43]. DExH/D-box helicases are a family of proteins and their function is
the unwinding of RNA [44]. For this process they use the energy from the hydrolysis
of ATP or other nucleotide triphosphates.
The process of splicing occurs via the assembly of the spliceosome, followed by rear-
rangements of the RNA-RNA network, and thereby, creation of an active catalytic
center in the spliceosome. This catalytic center is then formed by RNA molecules.
The complicated but particular eective way of forming an active site prevents un-
predictable splicing [38].
In the rst step of the splice cycle the U1 snRNP recognizes the 5'SS by basepair-
ing. This is an ATP-independent reaction and leads to formation of the E complex.
Then, the U2 snRNP binds to the BS by base-pairing (see g. 6) and the A complex
is formed. In the next step, the pre-formed U4/U6.U5 tri-snRNP is recruited to the
spliceosome. The formed spliceosomal complex is denoted as the B complex which
does not yet have an active catalytic center. The spliceosome is subsequently acti-
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Figure 6: The assembly cycle of the spliceosome. (Figure taken from [40])
vated for the rst catalytic step: rst, by the action of the DExH/D-box ATPases
Prp28 and Brr2, in cooperation with the GTPase Snu114 and second, by the remod-
eling of the spliceosome's RNA-RNA interaction network (this complex is termed
the Bact complex). The necessary rearrangements include the displacement of the U1
and U4 snRNAs and the formation of new base-pair interactions of U6 snRNA with
U2 snRNA and the 5'SS. The resulting RNA structure forms the core of the catalytic
center [45] [44] [46]. During the transition into the Bact complex, all U1 and U4/U6 pro-
teins are released and approximately 20 proteins are stably recruited. There are
large changes in the protein composition (see gure 7). Part of the recruited pro-
teins are eight proteins of the Nineteen Complex (NTC) and 12 additional proteins,
which are denoted as NTC-related proteins [47] [37] [48]. The Bact complex then has a
catalytic center which is inactive.
For the rst catalytic step of the splice cycle three proteins are necessary: Prp2,
Spp2, and Cwc25 [49] [50] [51] [48] [52]. Prp2 is a DEAH-box ATPase and Spp2 is its co-
activator. Both proteins are needed for the ATP-dependent creation of the active
site of the catalytic center for the rst step and large changes in the structure of
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the spliceosome are induced by their action [50] [48] [53]. The newly formed complex is
called the B* complex. During the transition from the Bact into the B* complex, a
substantial structural change occurs. This is seen by a shift in the sedimentation
rate of the Bact complex (45 S) into the B* complex (40 S). Additionally, changes
in the composition of the spliceosome occur. Two NTC-related proteins, Cwc24
and Cwc27, are displaced and the binding of the U2 SF3a/SF3b and RES complex
proteins is destabilized [54]. Because of the rearrangements, the adenosine of the BS
becomes accessible for the nucleophilic attack of the 5'SS [48] [53]. Thereby, the free
5' exon and the lariat-3'-exon intermediate are generated.
Figure 7: Compositional dynamics of yeast spliceosomes. The snRNP and protein
compositions of the B, Bact and C complex are shown. The complexes were analyzed by
mass spectrometry. Arrows depict the recruitment and release of dierent proteins. The
NTC complex is shown in red, the Bact complexes in brown and the proteins of the C
complex in purple. (Figure adapted from Fabrizio et al., 2009 [37])
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After completion of the rst catalytic step, the spliceosomal C complex is formed.
The compositional dynamics of yeast spliceosomes at the stages of the B, Bact, and
C complexes are summarized in gure 7.
In the next step, this complex has to be remodeled for the second catalytic step.
The activation is achieved by the DEAH-box ATPase Prp16. By the hydrolysis of
ATP by Prp16, the 3'SS is rearranged [55] and Slu7, Prp18, and Prp22 are neces-
sary for an ecient second catalytic step. All four proteins, Prp16, Slu7, Prp18,
and Prp22, are not present in the Bact complex [48] [46]. The function of Slu7 and its
heterodimeric complex partner Prp18 is to dock the 3'SS into the active site of the
catalytic center [56] [46]. Then the 3' hydroxyl group of the 5' exon can attack the
3'SS and the exons are ligated. After the second catalytic step, the mature RNA is
dissociated from the spliceosome induced by the action of the DEAH-box ATPase
Prp22. This helicase disrupts the contacts between the mRNA and the U5 snRNP
and promotes the release of the mRNA [57].
After the release of the mRNA, the disassembly of the intron-lariat complex is ac-
tivated by Prp43 and the spliceosomal factors can be recycled for a new round of
splicing. Comparable to Prp2, Prp43 needs a co-factors. This co-factor Ntr1 mod-
ulates the weak activity of Prp43 [58].
It was shown, that most of the snRNPs and proteins are recruited to the spliceosome
or dissociate from it at stages where they perform their respective functions. These
RNP rearrangements involve the transfer of proteins to new interaction partners [59].
All rearrangements in the RNA-RNA network and changes in the protein compo-
sition during the splice cycle require driving forces. The DExD/H-box helicases
(composed of DEAD-box, DEAH-box and Ski2-like helicases) are involved in these
steps by remodeling RNA-RNA, RNA-protein and protein-protein interactions and
are shown in table 1 [60] [59].
The most interesting helicases for the present study are Prp2, Prp16, Prp22, and
Prp43. These helicases are involved in the activation of the spliceosome for the cat-
alytic steps, the catalytic steps themselves, and the disassembly of the spliceosome.
1.2.4 The second catalytic step in detail
Step 2 factors, i.e. Prp16, Slu7, Prp18, and Prp22, are important for the remodeling
of the spliceosome for the second catalytic step. Their role in the formation of an
active site for the second step and the ligation of the exons is poorly understood.
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Helicase family ATPase Function in splice cycle
DEAD-box Sub2 Pre-spliceosome
DEAD-box Prp5 Pre-spliceosome
DEAD-box Prp28 Early activation
Ski2-like Brr2 Early activation
DEAH-box Prp2 Late step-1 activation
DEAH-box Prp16 Step-2 activation
DEAH-box Prp22 mRNA release
DEAH-box Prp43 Disassembly
Table 1: ATPases of the yeast spliceosome and their role in the splice cycle.
Also, the time points of their recruitment are uncertain. It is known, that the
spliceosome is rearranged by the hydrolysis of ATP by Prp16 and because of these
rearrangements the 3'SS becomes protected against DNA-directed RNaseH cleav-
age [55]. It was assumed that Prp16 dissociates from the spliceosome concomitantly
with ATP hydrolysis and then the other step 2 factors are recruited [55,56]. Further
studies suggested, that Slu7 is involved in the selection of the 3'SS because of its
possible crosslink to the 3'SS during the second step [61,62].
After the binding of Slu7 and Prp18 to the spliceosome, Prp22 is recruited [56]. One
of its functions is the release of the mRNA from the spliceosome. This process is
ATP-dependent, but Prp22 also has an ATP-independent function, which is the
promotion of the second catalytic step [63,64]. Immunoprecipitation studies on the re-
cruitment of the second step factors were done with Slu7-, Prp18-, or Prp22-depleted
yeast extracts and showed, that after the hydrolysis of ATP by Prp16, rst Slu7 is
bound, then Prp18, and in the end Prp22. After this ordered recruitment, all three
proteins promote the second catalytic step [56].
Previous depletion/reconstitution studies showed further that the requirement of
the second step factors is less strict if the distance between the branch site and
the 3'SS is short [65] [66] [64] [56]. Studies on the order of recruitment were based on
an actin pre-mRNA substrate with a distance of 38 nt between BS and 3'SS. This
distance was then shortened down to 7 nt and a less strict ordered recruitment was
observed [66]. Because of the use of only whole cell extracts, immunodepletion and
immunoprecipitation techniques had to be used. These techniques have limitations
which did not enable clear observations of the action mechanism of the step 2 factors
during the second step catalysis.
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Until now it is unclear, how the C complex is restructured during the Prp16-mediated
catalytic activation. It has been hypothesized that the spliceosome has one single-
active site in the catalytic center [67]. Because of only one single active site, this site
has to be remodeled after the rst catalytic step for the second catalytic step. The
lariat has to be displaced and the 3'SS has to be in the catalytic center. Then it is
well positioned for the nucleophilic attack by the 5' exon. This is a dierent confor-
mational state than for the rst catalytic step. The substrates have to be bound in
dierent ways for both catalytic steps in two distinct conformational states [61] [40].
One assumption is that the spliceosome passes through the two dierent confor-
mations during the catalytic phase and a two-state model was proposed [68] (see
g. 8).
Figure 8: The two-state model for the catalytic steps. Scheme for the proposed
two-state model of the conformational states for the rst and second catalytic step. It
is assumed that the ATPase Prp16 facilitates the transition between the rst and second
steps. (Figure adapted from Konarska et al., 2005 [68])
In the two-state model, the conformational states exist at equilibrium. Studies with
mutant alleles in which some mutant alleles improved the rst step and inhibited the
second one and vice versa showed that the conformational states are competing with
each other [68]. This two-state model is comparable to the two-state model of the
ribosome. The ribosome switches between an open and a closed conformation during
the decoding of mRNA. Comparably, the spliceosome may switch between an open
and closed conformation during the catalytic steps. In this case, the transitions are
supported by proteins and helicases, i.e. the helicases Prp2 and Prp16 may facilitate
the transitions [68]. An open question is whether the structural change during the
transition is accompanied by remodeling events comparable to the remodeling of the
Bact complex by the Prp2-mediated catalytic activation [54]. It was shown, that by
the action of Prp16, two proteins, Cwc25 and Yju2, are displaced [69]. It is unclear
whether the action of additional step 2 factors is necessary for their displacement
and whether the formation of the active site for the second catalytic step requires
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only Prp16 or another step 2 factor. Further step 2 factors could help to form
the active site or stabilize the step 2 conformation. These factors could be Cwc25,
Slu7, Prp18, and Prp22. The question about the proteins necessary for the step 2
conformation is poorly answered until now. The assumption that the docking of the
3'SS into the step 2 active site may stabilize the catalytic center for step 2 catalysis
has to be tested.
In this study, the role of the step 2 factors in the splicing of yeast pre-mRNA is
investigated and a splicing system in which the spliceosomal complexes are stalled
at the Bact stage was used. This complex can be complemented with recombinant
proteins, i.e. step 1 and step 2 factors, to activate the complex for the catalytic
steps and to let it run through the catalytic steps.
The binding behavior of the following proteins was observed with FCCS:
Snu114 U5snRNP protein
Cwc25 Step 1 splicing factor
Prp16 Step 2 splicing factor
Slu7 Step 2 splicing factor
Their binding to the Bact, B*, C, C*, and C2nd complex was investigated to ana-
lyze their recruitment order to the spliceosome. The spliceosomal complexes under
investigation are shown in gure 9.
Figure 9: Spliceosomal complexes to which the binding of several proteins was observed
with FCCS.
The binding of Cwc25, i.e. a step 1 factor and the following questions were investi-
gated: when is Cwc25 bound to the spliceosomal complexes? When is it released?
How does it bind to dierent pre-mRNA substrates? What is its role in the catalytic
steps? By using dierent pre-mRNA substrates, i.e. with a longer distance between
BS and 3'SS and with a shorter distance between these, dierences in the recruit-
ment of the step 2 factors can be observed. The minimal requirements of proteins
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for the second step can be dened. The question, whether Slu7 and Prp16 have the
same binding site on the spliceosome or not is investigated.
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2 Materials and Methods
2.1 Dual-Color Fluorescence Cross-Correlation Spectroscopy
Dual-Color Fluorescence Cross-Correlation Spectroscopy (FCCS) is a uorescence
spectroscopy method based on Fluorescence Correlation Spectroscopy (FCS). FCS is
a sensitive, optical method which provides information about molecules by analyzing
uctuations in a uorescence signal.
The experimental setup of FCS is based on a confocal microscope. Its key feature is
the diraction-limited excitation of a uorescent sample and confocal detection (see
g. 10). In general, the excitation light is focused by an objective into the sample
solution. The uorescence light is then collected by the same objective and passed
through a pinhole. Only uorescence light generated very close to the focal plane
can pass through the pinhole, whereas out-of-focus light is blocked. Combining
focused illumination and a pinhole, only light from a very small volume is detected
by the photo detector. This detection volume is described by a convolution of the
volume created by the focused laser beam and the detection system including the
objective, the pinhole, any lens, or lter. It is basically an region in solution in which
molecules are uorescently excited and uorescence detection takes place. The shape
of the detection volume is described by a three-dimensional Gaussian ellipsoid with
a few hundred nanometers in focus diameter and one to two micrometer along the
optical axis [70]. The exact shape of the detection volume depends on the quality
of the optical elements and can be changed by several parameters, e.g. coverslide
thickness or laser intensity [13,71].
In an FCS experiment, single molecules carrying a uorophore diuse through the
detection volume. Typically, the emitted photons are detected by single-photon
avalanche diodes and the time-dependent intensity uctuations are analyzed by a
temporal auto-correlation analysis of the uorescence signal. From this analysis the
translational and rotational diusion of a uorescent molecule can be determined.
Additionally, information about the average number of molecules in the observation
volume and triplet state dynamics of the uorophores are accessible [13,71].
FCS can be used for determining diusion coecients but has only limited accuracy
in observing binding reactions. For observing binding interactions FCCS can be
used.
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2.1.1 Principle of FCCS
In FCCS, two species of molecules are labeled with two dierent uorophores with
separated excitation and emission spectra. A typical FCCS setup is shown in g-
ure 10.
Figure 10: Confocal microscope setup for Dual-Color Fluorescence Cross-
Correlation Spectroscopy. A green and red laser beam are combined and injected into
a confocal microscope. The uorescent light of two uorophores with separated emission
spectra is spectrally resolved and detection is done by single photon detectors.
The sample is excited by a green and red laser. The beams of both lasers are
combined and reected into the objective by a dichroic mirror. The objective then
focuses the beams into the sample solution. Thereby, two overlapping confocal vol-
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umes of dierent colors are generated. The uorophores are excited and the emitted
light passes through the objective, the dichroic mirror, and a pinhole. The dierent
uorescence signals are separated according to their wavelength by a second dichroic
mirror. Detection is done by photon detectors in a spectrally resolved manner for
the red and green uorescence signals.
In principle, there are three dierent types of molecules in the sample: molecules la-
beled with a uorophore with a shorter excitation wavelength (hereafter denoted as
green labeled molecules or g), molecules labeled with a uorophore with a longer ex-
citation wavelength (hereafter denoted as red labeled molecules or r), and complexes
consisting of both molecules and carrying both uorophores (hereafter denoted as
green/red complexes or gr). For each detection channel the uorescence signals over
time of the dierent species can be monitored and the time-dependent uctuations
can be observed in each channel (gure 11).
Figure 11: Detection principle of Dual-Color Fluorescence Cross-Correlation Spec-
troscopy (adapted from Lakowicz [13]).
If a green labeled molecule diuses through the detection volume, there is only a
signal in the green detection channel. The same applies for the red labeled molecule.
If the green/red labeled complex, which consists of the green and the red labeled
molecule, diuses into the volume, a signal is observed in both channels (the green
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one and the red one). To analyze the binding behavior of the green labeled molecule
to the red labeled molecule, the cross-correlation between both signals is calculated.
If the molecules are not bound and diuse separately, the uorescence signals are
uncorrelated. Only the signals from bound molecules, which move together through
the confocal volume, are correlated. Calculating the cross-correlation between both
uorescence signals yields information about the binding behavior between the two
molecules. The cross-correlation amplitude is directly proportional to the number
of molecules which carry both uorophores, the green one and the red one. A
low cross-correlation amplitude corresponds to a low binding anity between the
molecules and a high cross-correlation amplitude reects a high binding anity of
the molecules. An example for the cross-correlation amplitudes is given in gure
12. There, a green labeled molecule interacts with a red labeled molecule. If the
red labeled molecule is bound to the green labeled molecule, the cross-correlation
amplitude is large. If the red labeled molecule is released, the cross-correlation am-
plitude is small.
Figure 12: Principle of FCCS: A high cross-correlation amplitude corresponds to the
binding of one molecule to another one and a low cross-correlation amplitude reects the
release of one molecule from the other one.
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2.1.2 Theoretical background of FCCS
In FCCS, the uorescence intensities Ig and Ir of the uorophores are detected in
dierent channels. For these intensities, the Auto-Correlation Function (ACF) for
the green (g) and red (r) channel, respectively, can be calculated:
gg(τ) = ⟨Ig(t) ⋅ Ig(t + τ)⟩t (1)
gr(τ) = ⟨Ir(t) ⋅ Ir(t + τ)⟩t (2)
I(t) is the uorescence intensity at time t and I(t + τ) is the intensity at time t + τ
with a time shift (lag time) τ between the two signals.
The ACF is directly proportional to the probability to detect a photon at time τ if
there was a photon detection event at time zero. This probability consists of two
terms: The rst term contains the correlated signals and the photons from the same
molecule. These photons are physically correlated. The second term results from
uncorrelated signals, i.e. from photons which were emitted by dierent molecules.
The backscattered laser light also contributes to this term. The uncorrelated signals
have no physical correlation but contribute to a constant oset of the ACF.
In FCS and FCCS, the correlation functions are usually normalized and the intensity
uctuations δI(t)
δI(t) = I(t) − ⟨I(t)⟩ (3)







and the normalized correlation functions are given by
Gg =
⟨Ig(t) ⋅ Ig(t + τ)⟩
⟨Ig(t)⟩2




⟨Ir(t) ⋅ Ir(t + τ)⟩
⟨Ir(t)⟩2
− 1 = ⟨δIr(t) ⋅ δIr(t + τ)⟩
⟨Ir(t)⟩2
(6)
Figure 13 shows an example for an auto-correlation curve. For small lag times τ ,
the amplitude of the ACF is high because the molecule with the uorophore is still
in the confocal volume. A photon emitted at time t will be also emitted from the
same uorophore at time t + τ . If the molecule diuses out of the confocal volume
at higher lag times, the possibility to detect two photons from the same uorophore
will be reduced. The curve decays to zero.
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Figure 13: Example of an auto-correlation curve with the diusion time τD.
By calculating the ACFs of the green and the red signal, information about the
temporal uctuations of the uorescence signal of the green and red molecules are
obtained. From this data, the diusion coecient D of the molecules can be deter-
mined. The diusion time τD of a molecule is dened as the average residence time
of the dye in the confocal volume. It has to be kept in mind that the ACF of one
color arises from two contributions: the uorescence signal of free, i.e. green labeled
molecules, and green labeled molecules which are bound to red labeled molecules.
To observe the diusion coecient of a green/red complex as well as the amount of
green/red complexes, the Cross-Correlation Function (CCF) has to be calculated.
The Cross-Correlation Function between two spectrally distinct signals is given by:
ggr = grg = ⟨Ig(t) ⋅ Ir(t + τ)⟩ (7)
The normalized Cross-Correlation Function is:
Ggr =
⟨Ig(t) ⋅ Ir(t + τ)⟩
⟨Ig(t)⟩ ⟨Ir(t)⟩
− 1 = ⟨δIg(t) ⋅ δIr(t + τ)⟩⟨Ig(t)⟩ ⟨Ir(t)⟩
(8)
The calculation of a CCF is similar to an ACF, except that the photons from dif-
ferent detection channels are correlated and only photons from molecules which
carry both uorophores (g and r) are contributing to the CCF. Fluorescence signals
from molecules which do not form complexes but are diusing through the confocal
volume at the same time are uncorrelated. They contribute to the oset of the CCF.
To describe the detected uorescence signal in an FCCS experiment, the dierent
uorescently labeled molecules have to be considered. A general approach is to
assume n dierent uorescent species. The uorescence signal is then given by the
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with the detection eciency βi, the extinction coecient εex,i, the quantum yield
φi, and the concentration Ci(r⃗, t) of the uorescent species i. In a typical FCCS
experiment, two species are present (n = 2).
Iex(r⃗) is the intensity prole of the excitation laser. S(r⃗) is the Collection Eciency
Function (CEF). This function describes the fraction of photons which are emitted
by a point source, pass through the pinhole, and are seen by the detector. The
value of S(r⃗) depends on the location and size of the image of a point emitter
with respect to the pinhole [72] [73] [74]. The CEF is also connected to the Molecular
Detection Function (MDF). This is the CEF multiplied by the excitation intensity
Iex and divided by the amplitude of the excitation intensity I0:
W (r⃗) = Iex(r⃗)
I0
S(r⃗) (10)
Important parameters for the Molecular Detection Function are the spatial dimen-
sions of the focused laser beam, the laser beam intensity, and the CEF. The MDF
takes into account the excitation probability and how a point emitter is imaged by
an optical system.
The spatial distribution of the MDF W (r⃗) is approximated by a three-dimensional
Gaussian model [73] and describes the detection volume:







with the lateral radius of the detection volume ω0. ω0 is dened as the radius at
which the intensity of the laser has decreased to a value of 1/e2. 2z0 is the axial
length of the detection volume.
Substituting the denition of the molecular brightness (ηi = βiεex,iφiI0) and the MDF







W (r⃗)ηiCi(r⃗, t)d3r⃗ (12)







W (r⃗)δ(ηiCi(r⃗, t))d3r⃗ (13)
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By inserting eq. 13 in the formula for the auto-correlation function (eq. 5), the
correlation curves can be derived. For the case of only one labeled species (n = 1),
the ACF is given by
G(τ) = ∫V ′ ∫V W (r⃗)W (r⃗
′) ⟨δ(ηC(r⃗, t))δ(ηC(r⃗ ′, t + τ))⟩d3r⃗d3r⃗ ′
(∫V W (r⃗) ⟨ηC(r⃗, t)⟩d3r⃗)
2 (14)
The uctuation term can be converted into
δ(ηC(r⃗, t)) = C(r⃗, t)δη + ηδC(r⃗, t) = ηδC(r⃗, t) (15)
with the constant brightness δη = 0.






Further, the concentration correlation function Φ is dened as
Φ(r⃗, r⃗ ′, τ) = ⟨δC(r⃗, t)δC(r⃗ ′, t + τ)⟩ (17)
For a translationally diusing molecule without internal dynamics the concentration
correlation function [71] is given by
Φ(r⃗, r⃗ ′, τ) = ⟨C(r⃗, t)⟩(4πDτ)3/2 exp(−
(r⃗ − r⃗ ′)2
4Dτ
) . (18)
This equation is the solution of the diusion equation. Equation 18 includes the
probability to nd a molecule at position r⃗ ′ at time τ which was at position r⃗ at
time zero. This probability is multiplied with the average concentration and D is the
diusion coecient of the molecule. With the concentration correlation function,
the auto-correlation can be written as
G(τ) = ∫V ′ ∫V W (r⃗)W (r⃗
′)Φ(r⃗, r⃗ ′, τ)d3r⃗d3r⃗ ′
















With the mean particle number ⟨N⟩ = Var(N) = ⟨δN2⟩ = ⟨C(r⃗, t)⟩Veff , the diusion
time τD = ω
2
0
4D , and the parameter a = z0/ω0.
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For a lag time τ = 0, considering only one species (n = 1) and a uorophore which is
not in the triplet state, and the case that the uorescence signal is proportional to









Equation 22 shows that the amplitude of the normalized auto-correlation curve at
lag time zero and the average number of molecules in the detection volume are
inversely proportional. It has to kept in mind that photophysical eects can change
the molecular brightness and the uorescence intensity uctuations. These changes
can inuence the correlation curve [23].
The number of molecules N depends on the size of the detection volume and on the
concentration of the molecules [20]. N varies with the wavelength λ of the excitation








Consequently, even for equal concentrations of both species, the number of molecules
in the detection volumes for both excitation wavelength will be dierent.
For an analysis of FCCS data, all equations have to be formed for both auto-
correlation functions (Gg(τ) andGr(τ)) and for the cross-correlation function (Ggr(τ)).
The intensity uctuations are given by
δIg(t) = ∫
V
Wg(r⃗)ηgδ(Cg(r⃗, t) +Cgr(r⃗, t))d3r⃗ (24)
δIr(t) = ∫
V
Wr(r⃗)ηrδ(Cr(r⃗, t) +Cgr(r⃗, t))d3r⃗ (25)
Assuming that the detection volumes of both colors (green and red) are ideally











(⟨Cg⟩ + ⟨Cgr⟩)(⟨Cr⟩ + ⟨Cgr⟩)Veff
(28)
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(⟨Cg⟩ + ⟨Cgr⟩)(⟨Cr⟩ + ⟨Cgr⟩)Veff
(32)
Substituting ⟨N⟩ = ⟨C(r⃗, t)⟩Veff , the correlation functions are coupled to the parti-











(⟨Ng⟩ + ⟨Ngr⟩)(⟨Nr⟩ + ⟨Ngr⟩)
(35)
These equations show the relation between the amplitudes of the correlation func-
tions and the number of particles in the detection volumes. Comparison of the
numerators of the equations 33 - 35 shows that for Ngr >> Ng,Nr the amplitudes
of the auto-correlation functions are always higher or equal to the amplitude of
the cross-correlation function [19]. The cross-correlation amplitude Ggr(0) is directly
proportional to the number of particles which carry both labels, because the de-
nominator in equation 35 is constant in time [19]. Changes in the number of double
labeled particles Ngr caused by binding or dissociation reactions results in changes
of the cross-correlation amplitude. These variations can be monitored and allows
for determining the binding behavior of molecules.
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2.1.3 Limitations of FCCS
While FCCS allows for observation of binding reactions, it has some limitations,
with respect to sample preparation, excitation, and detection.
For FCCS measurements the molecules of interest have to be labeled with high
labeling eciency and each molecule has to be labeled with only one uorophore (1:1
labeling). The molecules of one species should only carry the same uorophore (e.g.
the green uorophore) and the molecules of the second species another uorophore
(e.g. the red uorophore). Another limitation is the binding anity of the molecules.
If the binding anity is too low, a higher concentration of particles is necessary
and too many particles are in the detection volume [24]. These are sample related
limitations.
Additionally, there are limitations and intrinsic problems on the excitation and
detection side [15]. One problem is cross-excitation. The red uorophore can be
excited by the green excitation wavelength (cross-excitation). This cross-excitation
can be reduced by choosing dyes with dierent uorescence spectra which have only
a small overlap. The absorption spectra of the used dyes and the lines of both
excitation lasers are shown in gure 14 and illustrate that the green laser can excite
the red dye only to a very small extent. Cross-excitation of the green dye by the
red laser is negligible by energetic reasons.
A further problem is cross-talk between detection channels. Cross-talk results from
green light coupling into the red detection channel and red light coupling into the
green channel. These cross-emissions can be suppressed by choosing suitable emis-
sion lters. The emission spectra of the used dyes (eGFP, Alexa488, and Atto647N)
and transmission spectra of the used emission lters are shown in gure 14. Fig. 14b
illustrates that cross-talk resulting from green emission into the red channel is sup-
pressed in our system.
Another way for reducing spectral cross-talk and which is used is Pulsed Interleave
Excitation (PIE) [75] [25]. PIE is based on the use of alternating excitation pulses. The
uorescence emission generated from one pulse has decayed before the next pulse
excites the uorophores. By using interleaved pulses in the sequence of green pulse,
red pulse, the excitation source of each detected photon is known and cross-talk is
reduced.
Additionally, the two detection volumes have to overlap to excite the two dierent
uorophores on one green/red complex simultaneously. Due to the dierent excita-
tion wavelengths, dierent beam waists, and dierent divergences of the laser beams,
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the detection volumes have dierent sizes. This leads to two non-ideally overlapping
foci. To involve this factor in the analysis, a sample with 100 % cross-correlation is
measured. By assuming 100 % cross-correlation, a correction factor for the detection
volumes is calculated.
Figure 14: Emission and transmission spectra. a) Emission spectra of the used dyes
(blue: Alexa488, green: eGFP, red: ATTO647N) and transmission spectra of the dichroic
in front of the objective; b) Emission spectra of the used dyes and transmission spectra of
the used emission lters; c) Absorption spectra of the used dyes and lines of the excitation
lasers.
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2.1.4 Dual-Focus Fluorescence Cross-Correlation Spectroscopy
The setup used for FCCS measurements allows for simultaneously performing Dual-
Focus Fluorescence Correlation Spectroscopy (2fFCS) [76]. 2fFCS is an extension
of conventional FCS and allows for determining absolute diusion coecients with
high precision.
Figure 15: Schematic picture of the 2fFCS setup. Two identical lasers with per-
pendicular polarization (shown by arrows) are combined and reected up into a Nomarski
prism and the objective. The uorescence light is collected by the same objective, passes
through dierent optical elements, and is focused onto two detectors
(adapted from Dertinger et al. [77]).
In 2fFCS two pulsed excitation lasers with identical wavelength and perpendicular
polarization are used. A Nomarski prism is placed in front of the objective. The
laser beams are combined and reected into the Nomarski prism by a dichroic mirror
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(see g. 15). Due to their perpendicular polarizations, the laser beams are deected
by the Nomarski prism under dierent angles (shown in g. 16). Afterwards, they
are focused by the objective into the sample solution and two identical but laterally
shifted and overlapping foci are generated. The distance δ between the foci de-
pends on the properties of the Nomarski prism and the wavelength of the excitation
beam. For a specic wavelength, the distance is xed and constitutes an intrin-
sic ruler to the system. Fluorescence is then collected by the same objective and
Figure 16: Schematic of a No-
marski prism. The ordinary and ex-
traordinary rays correspond to the laser
beams with perpendicular polarization
(adapted from www.microscopyu.com)
passed through the Nomarski prism, the
dichroic mirror, and the pinhole. After the
pinhole, the light is split and focused onto
single-photon counting detectors. Using a
single-photon counting device which detects
the arrival times of each recorded photon al-
lows for determining which uorescent photon
was generated by which laser. Then Auto-
Correlation Functions for each focus and the
Cross-Correlation Function between both foci
can be calculated. Knowledge of the dis-
tance δ allows for calculating absolute values
of the diusion coecient from the ACFs and
CCF [77].
The theory of 2fFCS is similar to the theory of FCCS. In the case of 2fFCS, the
signals of the two shifted foci are cross-correlated:
GCC,1(τ) =




⟨δI2(t) ⋅ δI1(t + τ)⟩
⟨I1(t)⟩ ⟨I2(t)⟩
(37)
with the intensity signal I1 from focus 1 and I2 from focus 2.
In order to obtain accurate diusion coecients, an appropiate model function for
the MDF is important. This MDF can be approximated by a Gauss-Lorentzian
function [76]:
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In this model, a Gaussian distribution in each plane perpendicular to the optical
axis with the width ω(z) and the amplitude κ(z)/ω2(z) was approximated. The
functions ω(z) and κ(z) are given by
ω(z)2 = ω20
⎡⎢⎢⎢⎢⎣





κ(z) = 1 − exp(− 2α
2
R2(z)) (40)
The function R(z) is dened by:
R(z)2 = R20
⎡⎢⎢⎢⎢⎣





λex denotes the excitation wavelength, λem the emission wavelength, n is the refrac-
tive index of the immersion medium, and α is the radius of the confocal aperture
dened by the magnication of the system. ω20 and R
2
0 are unknown model parame-
ters. With the modied MDF, the cross-correlation function between two laterally

























Here, η1,2 are two factors which represent the excitation intensities of each focus,
the detection eciencies, and the uorophores properties.
The obtained diusion coecient in an FCS experiment strongly depends on the
shape of the detection volume. Variations in the excitation laser intensity, in the
coverslide thickness, and in the refractive index of the sample can inuence the
shape of the observation volume. These problems require a calibration of the system
prior to each measurement. This can be overcome by using 2fFCS. The mentioned
parameters, e.g. the laser intensity, can change the size and shape of the detection
volume of each focus but not the distance between them. Therefore, 2fFCS allows
for observing absolute diusion coecients without calibration of the setup prior to
each measurement.
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2.1.5 Dual-color dual-focus Fluorescence Cross-Correlation
Spectroscopy
In the used setup, the two methods FCCS and 2fFCS are combined. Combining
2fFCS and FCCS allows for precisely calculating diusion coecients while perform-
ing highly accurate binding studies. In more detail, for each excitation wavelength
(green and red) two lasers with perpendicular polarization are used. By using a
Nomarski prism, laterally shifted foci are generated. Thereby, two laterally shifted
green foci are overlapping with two laterally shifted red foci. For the calculation of
the number of complexes (gr), all Auto-Correlation and Cross-Correlation Functions
between the foci and the colors have to be determined (see section 2.1.7).
Figure 17: Exemplary representation of correlation curves in an FCCS exper-
iment. The green line and symbols denote the cross-correlation between the two colors,
the blue line and symbols the auto-correlation for both green foci and the red line and
symbols the auto-correlation for both red foci. The correlation curves are normalized and
show the binding of Cwc24-eGFP to Bact∆Prp2.
Typical normalized correlation curves of a dual-color-dual-focus FCCS measurement
are shown in gure 17. The amplitude of the Cross-Correlation Function between
both colors (green-red) is smaller than the amplitude of both Auto-Correlation Func-
tions of the foci (green-green, red-red). This can be also shown by comparing the
amplitudes of the correlation functions (eq. 33 - eq. 35):
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Ggr(0)
Gr(0)




= ⟨Ngr⟩⟨Nr⟩ + ⟨Ngr⟩
(44)
2.1.6 Used optical setup for the FCCS experiments
Figure 18: The used optical setup for FCCS and 2fFCS experiments.
The dual-color FCCS setup is based on an inverse epi-uorescence microscope (Mi-
croTime 200, PicoQuant GmbH, Berlin, Germany) with a 2fFCS extension [76]. The
system is equipped with two identically pulsed 480 nm diode lasers (LDH-P-C-485
B, PicoQuant GmbH, Berlin, Germany) and two identically pulsed 635 nm diode
lasers (LDH-P-635, PicoQuant GmbH, Berlin, Germany) with linear polarization
and a pulse duration of 50 ps (FWHM). The lasers are pulsed alternately with an
overall repetition rate of 10 MHz (PIE mode) [75] corresponding to a delay of 25 ns
between pulses (PDL 828 Sepia II, PicoQuant GmbH, Berlin, Germany).
The light of each of the two pairs of identical wavelength lasers is combined by two
polarizing beam splitters (Ealing Catalogue, St. Asaph, UK) into single beams.
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These beams are combined by a dichroic mirror (490 dcxr, Chroma Technology,
Rockingham, VT, USA) resulting in a single beam containing both wavelengths. The
beam is coupled into a polarization-preserving single mode ber. At the ber output,
the light is collimated and reected up by a dichroic mirror (Q660LP, Chroma Tech-
nology, Rockingham, VT, USA). Before entering the objective, the light is passed
through a Nomarski prism (U-DICTHC, Olympus Europa, Hamburg, Germany)
which deects the beam into two slightly dierent directions depending on their
polarization. Then, the light is focused into the microscope's objective (UPLAPO
60x W, 1.2 N.A., Olympus Europa, Hamburg, Germany) and two overlapping foci
with a xed lateral distance determined by the properties of the Nomarski prism
are obtained.
Fluorescence is collected by the same objective (epi-uorescence setup), passed
through the Nomarski prism and the dichroic mirror, and focused by a tube lens
through a single circular aperture (diameter 150 µm). After the pinhole, the light
is re-collimated, split by a polarizing beam splitter cube and a dichroic mirror (640
dcxr, Chroma Technology, Rockingham, VT, USA), and focused onto two single
photon avalanche diodes (SPAD, AQR13, Perkin Elmer, Wellesley, MA, USA), re-
spectively, for the red and the blue excitation. Emission bandpass lters HC692/40
and HC520/35 (Semrock, USA) for red and blue excitation, respectively, positioned
directly in front of each detector, discriminate uorescence against scattered light. A
single-photon counting electronics (HydraHarp 400, PicoQuant GmbH, Berlin, Ger-
many) independently records the detected photons of all detectors with an absolute
temporal resolution of 4 ps on a common time frame.
2.1.7 Computation and evaluation of the correlation data
All correlation curves are calculated by a dedicated software [78]. In the rst step,
the following functions are calculated: the Auto-Correlation Functions (ACFs) of the
focal volumes excited by the rst green laser (GG1), the second green laser (GG2),
the rst red laser (RR1), and of the second red laser (RR2). The corresponding
Cross-Correlation Functions between both green (GGX) and both red (RRX) focal
volumes are also necessary. Here, 1 denotes the focal volume of the rst laser, 2
denotes the focal volume of the second laser, and X denotes the focal volume of the
overlap between the volumes of the same color. In the same way, the correlation
functions for photon pairs of which the rst photon was excited by the rst green
laser and the second was excited by the rst red laser (GR1) are computed. The
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calculation is done accordingly for GR2, RG1, RG2, GRX, and RGX. Since the laser
settings and buer conditions are always constant during one set of experiments, a
blank measurement is done using only the buer as sample. The computation of
the correlation data in absolute units of cps2 allows for compensating for the buer
background by simple subtraction of the corresponding blank curves. In this way,
the number of data for the subsequent data evaluation can be reduced by setting
Gn = GGn −GG0n (45)
Rn = RRn −RR0n (46)
Mn =
(GRn −GR0n +RGn −RG0n)
2
(47)
where n can take the values 1,2,andX and the index 0 denotes the corresponding
data of the blank sample. These three sets of data are tted independently using
a standard model based on an appropriate approximation of the molecule detection
function [76]. The t parameters were equal for all three data sets. Generally, one
nds three types of molecules in solution: A fraction (g) that carries only the green
label, a fraction that carries only the red label (r), and a fraction of complexes which
carry both labels (m). From the ts of the correlation curves, the diusion constant
of the molecules, the amplitude acn of the diusion term, and the uncorrelated in-
tensity contribution bcn for each curve are obtained. Here, n stands for the focal
volume 1,2,orX and c for the observed color G,R,M . FCS theory predicts that
the relative amplitude γn = bGn /aGn is equal to the number of molecules within the




= N gn +Nmn (48)
where N gn and Nmn are the average numbers of green and mixed-colored molecules in












(N gn +Nmn )(N rn +Nmn )
(50)
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Typically, the focal volumes for the dierent colors do not have the same size. It is
impossible to directly solve these equations for the dierent numbers of molecules.
Instead, the focal volumes need to be calibrated. For this purpose, a diluted sample
of doubly labeled dsDNA (25-25 bases, FCCS Standard Probe, IBA GmbH, Göt-
tingen, Germany) was measured as a reference. Since this sample shows perfect
codiusion for all colors, one knows a priori that Ñ gn = Ñ rn = 0 (all symbols with
∼ denote the reference sample). In case of identical volumes, one would expect to
nd γ̃n = ρ̃n = 1/µ̃n. For the actual, non-identical volumes, the calibration factors
cgn = 1/γ̃nµ̃n and crn = 1/ρ̃nµ̃n are introduced. For the overlap between the red and the
green excitation/detection volume, the average number of molecules is then given
by the simple relations
N gn = cgnγn −Nmn (51)
N rn = crnρn −Nmn (52)
Nmn = µncgnγncrnρn (53)
The relative numbers of molecules given by the cross-correlation amplitudes are
calculated for each measurement. For the nal data analysis, the mean value and
the standard deviation of these two measurements are calculated.
The spectroscopic measurements were done by myself and I calculated all correlation
functions, including the analysis and evaluation of the data.
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2.2 Spliceosome purication, reconstitution, and labeling
The entire sample preparation was carried out by Dr. Peter Odenwälder, Dr. Julia
Dannenberg, and Dr. Thomas Ohrt from the group of Prof. Dr. Reinhard Lührmann
at the Max Planck Institute for Biophysical Chemistry. A list of the used materials
and a more detailed description of the biochemical methods are given in the PhD
Thesis of Dr. Julia Dannenberg and Dr. Peter Odenwälder.
2.2.1 The model system
In this study, spliceosomal complexes isolated from the yeast Saccharomyces cere-
visiae were used to investigate pre-mRNA splicing with FCCS. The yeast system is
the most favored model organism. A lot of protocols are given and allow for genomic
manipulation of the organism in an easy manner. It is possible to stall the spliceo-
somal complexes at dened stages because of given temperature-sensitive strains
for dierent proteins. Functional spliceosomal complexes on a complete pre-mRNA
strand can be puried and analyzed with various methods. The yeast proteins can
be overexpressed and puried in E.coli in an easy manner. Because of these facts,
the spliceosome can be assembled and reconstituted step by step and allows obser-
vations on dierent stages of the splice cycle.
Another important fact is the reduced number of involved proteins in a yeast
spliceosome in comparison to the human spliceosome or other higher eukaryotes.
Many splicing factors of the yeast spliceosome are evolutionarily conserved in hu-
man spliceosomes. The yeast spliceosome represents the core design of the splicing
machinery [37].
2.2.2 Spliceosome purication
Yeast spliceosomal complexes were puried essentially as described [37] except that
heat inactivated extracts from the yeast strain prp2-1 [79] were used in the assem-
bly reactions. Before splicing, Actin pre-mRNA wildtype or other constructs were
incubated with a 35-fold molar excess of puried MS2-MBP fusion protein at 4○C
for 30 min in 20 mM HEPES-KOH (pH 7.9). Depending on the required amount
of spliceosomal complexes, a 6 - 72 ml splicing reaction containing 1.8 nM of 32P-
labeled M3Act pre-mRNA (specic activity 20-300 cpm/fmol) was performed in
60 mM K-PO4 (pH 7.4) (phosphate buer was prepared by mixing solutions of
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K2HPO4 and KH2PO4 according to Sambrook et al. [80]), 3 % PEG 8000, 2.5 mM
MgCl2, 2.0 mM ATP, 2.0 mM spermidine, and 40 % yeast extract in buer D (see
table below). Bact complexes were assembled by incubation at 23○C for 50 min. 6 ml
aliquots of the splicing reaction were loaded onto 36-ml linear 10 - 30 % (w/w) glyc-
erol gradients containing GK150 or in some experiments GK75 buer. Gradients
were centrifuged for 14 h at 23,000 rpm in a SureSpin 630 rotor (Thermo Fisher
Scientic, Pittsburgh, USA) and harvested manually in 1500 µl fractions from the
top. Fractions were analyzed by Cherenkov counting in a scintillation counter and
peak fractions containing complexes were pooled and loaded onto columns contain-
ing 250-300 µl of amylose matrix equilibrated with GK75 or GK150 buer. The
matrix was washed twice with 10 ml GK150 buer and twice with GK75 buer
supplemented with 5 % glycerol and 0.01 % NP40, and spliceosomal complexes were
eluted stepwise with 750 µl elution buer. The elution fractions were either used
directly for reconstitution assays or for FCCS analysis or were loaded onto a 3.8-ml
linear 10 - 30 % (w/w) glycerol gradient containing GK75 buer. Gradients were
centrifuged for 107 min at 490,000 g in a Sorvall TH660 rotor, and 175 µl fractions
were harvested from the top of the gradient and analyzed by Cherenkov counting.
Peak fractions were then used for mass spectrometry analysis or used in reconstitu-
tion assays.
Buers for purication:
Buer D 20 mM HEPES-KOH pH 7.9
50 mM KCl
0.2 mM EDTA pH 8.0
20 % (v/v) glycerol
0.5 mM DTT
0.5 mM PMSF
GK150/GK75 buer 20 mM HEPES-KOH pH 7.9
1.5 mM MgCl2
150 or 75 mM KCl
Elution buer with 12-20 mM maltose
GK75 buer 5 % glycerol
0.01 % NP40
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2.2.3 Splicing reconstitution assays
10 fmol of Bact∆Prp2 complexes eluted from the amylose matrix or from peak frac-
tion(s) of the second gradient were supplemented with 100 fmol (10-fold molar ex-
cess) of recombinant proteins in a 40 µl reaction.
After incubating the reconstitution reaction for 10 min on ice, 1/10 volume of a
10-fold rescue solution was added to the reaction. The reactions were incubated
for 45 min at 23○C. After Proteinase K digestion, the RNAs were extracted by
phenol-chloroform-isoamyl alcohol (PCI) extraction, precipitated by ethanol, and
then analyzed by 8 % denaturing PAGE followed by autoradiography.
For reconstitution assays on the amylose matrix, complex concentration was de-
termined by Cherenkov counting and recombinant proteins were added in 10-fold
molar excess. A typical reconstitution reaction was performed with 250-300 µl amy-
lose beads in a nal volume of 500-600 µl in GK75 buer containing 50-60 µl 10-fold
rescue solution and were incubated at 23○C for 45 min. For ATP depletion, the
reaction was supplemented with 2 mM glucose and 2 units of recombinant hexok-
inase and incubated for 10 min at 23○C. The matrix was then washed thoroughly
with 100 column volumes of GK75 buer and the complexes were eluted with 12-
20 mM maltose. For dual-color FCCS measurements, reactions were carried out in
solution in a nal volume of 60 µl with a nal complex concentration of 1.0 nM.
The puried, labeled Bact∆Prp2 spliceosomes were then complemented with a 10-fold
molar excess of recombinant proteins and the extent of binding of Prp16 and Slu7
fused to EGFP or Cwc25-Alexa488 to the spliceosome was measured. Instead of
adding the 10-fold rescue mix, the reaction conditions were only adjusted to nal
concentrations of 2.5 mM MgCl2 and 2 mM ATP (or ATP analogues), as PEG8000
increased the background of the FCCS measurements.
10x rescue solution 200 mM phosphate buer K-PO4 (pH 7.3)
10 mM MgCl2
20 mM ATP
14 % PEG 8000
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2.2.4 Denaturing polyacrylamide gel electrophoresis
Gel electrophoresis is a method for separation of macromolecules, i.e. DNA, RNA,
and proteins, based on their size and charge. By applying an electric eld, negatively
charged molecules move through a polyacrylamide gel. This gel is a crosslinked
polymer with a mesh network. Smaller and thereby faster molecules migrate more
easily through the pores of the gel than larger molecules. The movement is also
inuenced by the charge density of the molecule. By using a denaturing gel, the
natural structure of the molecule is disrupted and it is unfolded into a linear chain.
The mobility of the molecule through the gel then depends on its linear length and its
mass-to-charge ratio [34]. Using denaturing polyacrylamide gel electrophoresis allows
for separating the splicing products, i.e. the RNAs up to 1500 bp in size. For the
denaturing of RNA, the gel contains 8M urea and acrylamide concentrations between
5 % and 10 %. The acrylamide polymerization was initiated by adding ammonium
persulfate and TEMED. The RNA samples were resuspended in RNA loading dye,
denatured at 70○C for 3 min, and loaded on the gel. For electrophoresis 1x TBE
buer (10x TBE buer: 0.89 M Tris, 0.89 M boric acid, 25 mM EDTA pH 8.0) and
a constant voltage were used. For a better separation of the splicing products and
intermediates, an optimized ratio of acrylamide to bisacrylamide of 29:1 was used.
The RNAs were visualized by autoradiography, which is a photographic technique
for detection of radioactive material, i.e. radioactive labeled nucleotides.
2.2.5 Labeling of spliceosomes
Proteins were genetically modied by fusion to enhanced green uorescent pro-
tein (eGFP). The dierent Bact∆Prp2 complexes were assembled in vitro using heat-
inactivated splicing extracts from yeast strains that were temperature-sensitive in
the ATPase Prp2 [79] and which stably expressed the protein of interest as an eGFP
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fusion protein. The puried, doubly labeled Bact∆Prp2 spliceosomes were then com-
plemented with recombinant Prp2, Spp2, and ATP. Recombinant Spp2 was always
added together with Prp2, as our puried Bact∆Prp2 complexes lack Spp2 [48]. Re-
combinant Cwc25 was chemically labeled with Alexa488 as described below.
Labeling of pre-mRNAs with a uorescent dye
Guanosine-5'-O-monophosphorothioate (5'-GMPS) can be incorporated as the rst
nucleotide by T7 RNA polymerase in vitro. 5'-GMPS-containing mature actin pre-
mRNA was prepared by in vitro transcription of Acc65I digested pUC18-Actin-wt
plasmid DNA with T7 RNA polymerase (40 mM Tris-HCl, pH 8.0, 30 mM MgCl2,
10 mM DTT, 2 mM spermidine, 0.1 U yeast inorganic pyrophosphatase (NEB),
0.5 U RNasin (Promega), 4 mM ATP, 4 mM CTP, 4 mM UTP, 1 mM GTP, 10 mM
5'-GMPS (Biolog); 37○C, 3 h). Transcripts were puried by electrophoresis through
5 % polyacrylamide, 8 M urea gels and passively eluted into 0.5 M NaOAc, pH 5.3,
1 mM EDTA, pH 8.0, 2.5 % phenol-chloroform-isoamyl alcohol. To link the 5'-
GMPS-modied pre-mRNA covalently to the uorescent dye Atto647N (ATTO-
TEC), Atto647N-maleimide was incubated with the pre-mRNA in the presence of
100 mM NaPO4 (pH 7.2) at RT for 4 h. The Atto647N-labeled pre-mRNA was pre-
puried by 4x ethanol precipitation and several washing steps to remove unreacted
dye, resulting in nearly 100 % labeled pre-mRNA. The dye:RNA stoichiometry was
calculated according to the manufacturer's protocol (Molecular Probes).
Expression and Purication of Prp16-EGFP and Slu7-EGFP
Full-length yeast PRP16 and SLU7 genes were cloned into pYES2/CT plasmid con-
taining an N-terminal His6-tag in frame with an N-terminal eGFP-tag and trans-
formed into the INVSc1 yeast strain (Invitrogen). Cells were grown to an OD600
of 4.0 in YP medium supplemented with 2 % galactose. Whole cell extract was
prepared as described [81]. His6-eGFP-Prp16 and His6-eGFPSlu7 were captured on a
Ni2+-NTA resin (GE Healthcare), eluted with the GK75 buer containing 200 mM
imidazole, and puried by size exclusion chromatography (S200 Sephadex 16/600
(GE Healthcare)) equilibrated with 20 mM HEPES pH 7.5, 200 mM NaCl, 20 %
(w/v) glycerol, and 2 mM DTT. Pooled fractions were dialyzed against 40 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 20 % (w/v) glycerol, and 1 mM DTT. Recombinant
Prp2, Spp2, Cwc25, Prp16, Slu7, Prp18 and Prp22 were expressed in E.coli and
puried as described previously [48].
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Labeling of Cwc25
Cwc25 does not contain any cysteine in its amino acid sequence. For uorescent
labeling a single cysteine at the C-terminus was added. The DNA sequence of the
construct was conrmed by sequence analysis. The cysteine mutant, Cwc25-C was
labeled with the uorescent reagent Alexa488-maleimide (Invitrogen). The labeling
was performed in 100 mM NaPO4-buer (pH 7.2) which contained 10 µM reducing
agent tris(2-carboxyethyl)phosphine (TCEP) (Sigma). The reaction mixture con-
tained 20 nM protein and 2 mM Alexa488-maleimide, which was added in DMF.
The reaction was allowed to proceed at 20○C for 2 h. The reaction was stopped by
adding GSH. Excess of the reagents was removed by gel ltration on a PD10 gel
ltration column equilibrated with GK75. The degree of labeling was calculated ac-
cording to the manufacturer protocol (Jena Bioscience) and yielded 73 % of labeled
Cwc25 at the C-terminus.
2.3 Measurement protocol
Spliceosome complexes were assembled on pre-mRNAs carrying the uorescent label
Atto647 at its 5'-end. The complexes were puried as described above and supple-
mented with recombinant proteins on a amylose matrix [54]. All samples were kept on
ice until the measurements. For the FCCS measurements, the complexes were mea-
sured in a volume of 25 µl at a concentration of 1.0 nM in a measurement chamber.
The chamber consisted of two glass coverslides connected through a 1 mm silicon
spacer (Grace Bio-Labs). To avoid unspecic binding to the coverslides during the
measurements, the coverslides were coated with Sigmacote (Sigma-Aldrich) accord-
ing to the manufacturer's instructions before the experiments. Two independent
measurements over 10 min of each sample were performed at room temperature.
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3 Results
In previous studies, changes in the protein composition and dynamics of the spliceo-
some were observed with biochemical methods, which provided initial indications of
the protein content and dynamics. Only little is known about the order of recruit-
ment, release, and degree of binding of the dierent spliceosomal proteins during
maturation and catalysis of the spliceosome. The ordered recruitment and release
of proteins and RNA is important for the spliceosome to become a functional mul-
tiprotein complex. To gain new insights into the dynamic behavior of spliceosomal
proteins in solution at low concentrations, FCCS is a powerful and ideal technique.
The advantage of using FCCS in solution is that the spliceosomal maturation can be
investigated in thermal equilibrium and in solution without the need of additional
purication steps.
Cwc22 was used to study the temporal stability of the spliceosome during FCCS
experiments because it is a splicing factor and not a core component of the spliceo-
some as shown by mass spectrometry [37]. To study the feasibility of FCCS for the
dynamic analysis of the spliceosome, the behavior of Snu114 tagged with eGFP
was investigated as this protein represents a stable component during spliceosomal
activation and catalysis [37,82]. Then, binding behavior and interactions of several
proteins (Cwc25, Prp16, Slu7/Prp18) at particular steps of the splice cycle were
studied.
3.1 Preliminary experiments for testing the availability of
FCCS on the spliceosomal complex
To test FCCS for monitoring the binding behavior of dierent spliceosomal proteins,
measurements on the Bact∆Prp2, B*, C, C*, and C2nd complex were performed. The
Bact∆Prp2 is the spliceosomal complex stalled before Prp2 action at the stage of the
Bact complex by using a temperature-sensitive Prp2 mutant [48] (see g. 19). The B*
complex is the Bact∆Prp2 complex complemented with Prp2, Spp2, and ATP. Further
addition of Cwc25 leads to the C complex. Complementation with Prp16 results in
the formation of the C* complex and further addition with Slu7/Prp18 leads to the
C2nd complex. In all measurements, the pre-mRNA was uorescently labeled with
the red dye Atto647N and the protein of interest was labeled with eGFP.
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Figure 19: Schematic representation of the experimental design and data. The
protein composition of the stalled, Prp2-decient Bact∆Prp2 complex is shown. The green
stars indicate the proteins labeled with eGFP. Box on the right site: representation of
the changes in the cross-correlation amplitude induced by release or binding of proteins.
(Figure adapted from Prior et al. [54])
In the FCCS measurements, the sample has to fulll the following criteria. First,
the sample has to be stable over 3 h at a concentration of ∼1 nM which would be
an indication of the stable integrity of the complex. Second, the complexes as well
as the supplied proteins should not aggregate during the measurements.
To check the sample stability over time, FCCS measurements on Cwc22 and the Bact
complex were performed and repeated after 3 h. Cwc22 was chosen because it gives
a good measure on spliceosomal integrity as it is not a core component but stably
bound during spliceosomal maturation [83]. The results are shown in gure 20.
The measurements showed that the criteria (no aggregation over 3 hours at ∼1 nM
concentration) are fullled indicated by comparable high cross-correlation ampli-
tudes around 35 %. The long lifetime and stability of the complexes was observed
by FCCS.
The correlation curves themselves could indicate the inuence of aggregation in
FCCS experiment and the curves for Cwc22's binding to the Bact complex at time
point zero and after 180 min are shown in gure 21. The correlation curves were
well-dened and could be tted perfectly even after 3 hours. This showed that
aggregation of complexes did not occur.
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Figure 20: Binding behavior of Cwc22-eGFP to the Bact complex at time point zero
and after 180 min. For each data point, the mean and the standard deviation of two
independent measurements were calculated.
Figure 21: Normalized data points and ts of the cross-correlation curves for Cwc22's
binding to the Bact complex at time point zero and after 180 min. Exemplary curves of
one measurement at time point zero and of one measurement after 3 h are shown.
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The following control experiments were performed to ensure that the puried spliceo-
somes behave in the same way in all FCCS experiments and that the addition of
further proteins has no disturbing eect. The well-characterized protein Snu114 was
chosen as this protein remains bound to the spliceosome and pre-mRNA from the
B complex over the complete splice cycle [82].
Figure 22: Binding behavior of Snu114-eGFP. Cross-correlation amplitudes for the
binding behavior of Snu114-eGFP to the spliceosomal complexes Bact∆Prp2, B*, C, C*,
and C2nd. For each data point, the mean and the standard deviation of two independent
measurements were calculated. (Parts of this gure also appeared in the PhD thesis of
Julia Dannenberg and are published in Prior et al. [54])
The results of the measurements on Snu114-eGFP are shown in gure 22. The cross-
correlation amplitude was at a high level of ∼57 % for the Bact∆Prp2 complexes which
contain Snu114-eGFP. This showed that the Bact∆Prp2 complex did not dissociate at
the conditions of the FCCS measurement.
By incubating Snu114-eGFP-Bact∆Prp2 with recombinant Prp2/Spp2 proteins plus
2.0 mM ATP for 45 min at 23○C, the catalytic activation of the complex was induced
and the B* complex was generated. As shown in gure 22, the cross-correlation am-
plitude for the B* complex was comparable to the one for the Bact∆Prp2 complex. The
relative number of Snu114-eGFP molecules bound to the complexes was constant at
a high level even upon the activation of the spliceosome.
When the spliceosome underwent the rst catalytic step, induced by the addition
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of Cwc25, Snu114-eGFP was still bound which was shown by a constantly cross-
correlation amplitude of over 55 %. The further addition of Prp16 and Slu7/Prp18
did not change the level of the cross-correlation amplitude and Snu114-eGFP was
stable bound when the spliceosome underwent the second catalytic step. These
measurements showed that the addition of proteins, for inducing the activation and
catalytic steps of the spliceosome, did not generate aggregations of complexes or
further artefacts. These measurements were performed at low salt concentration of
75 mM KCl.
Figure 23: Binding behavior of Snu114-eGFP at dierent salt concentrations.
Binding behavior of Snu114-eGFP to the spliceosomal Bact∆Prp2 and B* complex at dier-
ent salt concentrations (75 mM KCl, 150 mM KCl, 300 mM KCl). (Figure also appeared
in the PhD thesis of Julia Dannenberg and published in Prior et al. [54])
In the next experiment, the concentration of KCl was varied (75 mM, 150 mM,
300 mM) and the cross-correlation amplitude was measured for the Bact∆Prp2 and
B* complex. The higher salt concentration subjects the spliceosome to harsher con-
ditions, which allowed for testing the binding stability of Snu114 to both complexes.
The results are shown in gure 23. For both complexes, the cross-correlation am-
plitude was over 40 % at dierent salt concentrations. Even harsh conditions like
300 mM KCl did not change the binding anity of Snu114-eGFP to the Bact∆Prp2
complex. During the activation of the spliceosome by Prp2/Spp2 and at KCl con-
centrations of 150 mM or 300 mM, the cross-correlation amplitude remained at a
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high level of over 35 %, which indicates that Snu114-eGFP was still bound. These
results clearly show that Snu114 has a high-anity binding site in the Bact∆Prp2
and B* complex and is in agreement with published results [82]. Additionally, the
complexes are stable even at a concentrations of ∼1 nM.
Surprisingly, measurements at higher salt concentrations, i.e. 500 mM KCl, were
not possible because the spliceosomal complexes most likely aggregate and attach
to the glass surface of the used coverslides.
To conclude, FCCS is a powerful method for monitoring the binding of proteins
in a macromolecular complex at nanomolar concentrations from low to higher salt
concentrations. The measurements showed that FCCS is an ideal tool for observing
the dynamics of complex systems in solution and at equilibrium, and the method
provides a fast readout of results. An advantage of FCCS is the small sample volume,
which corresponds to small amounts of raw material.
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3.2 Recruitment and release of Cwc25-Alexa488 studied by
FCCS
The requirements for Cwc25's recruitment to and dissociation from the spliceosome
were investigated with FCCS. Measurements on spliceosomal complexes which un-
dergo the catalytic steps were performed. Dierent pre-mRNA substrates were used
to monitor the inuence of the substrate type on the binding of Cwc25.
3.2.1 Binding of Cwc25-Alexa488 to the actin wildtype pre-
mRNA
In the rst step, the binding behavior of Cwc25 to complexes assembled on actin
wildtype (Actwt) pre-mRNA was observed. For the experiments, puried Bact com-
plexes assembled on Actwt pre-mRNA were bound to an amylose anity matrix
and incubated with Prp2, Spp2, ATP, and Cwc25-Alexa488. By incubation with
hexokinase and glucose, ATP was removed. Afterwards, the column was washed
with GK75 buer. The produced C complexes were eluted from the anity matrix
with maltose. Additionally, Prp16 and Slu7/Prp18 were added to the solution. This
was done with and without ATP, or with non-hydrolysable ATP analog AMP-PNP
or AMP-PCP. The solutions were incubated for 45 min at 23 ○C and used for FCCS
measurements. In all measurements, the pre-mRNA was labeled with the red dye
Atto647N and Cwc25 was labeled with Alexa488.
The results of the FCCS measurements are shown in gure 24. The cross-correlation
amplitude for the Bact complex supplemented with Cwc25-Alexa488 was ∼1 % (col-
umn Bact in gure 24). This shows that Cwc25 cannot bind to the Bact complex.
The low cross-correlation amplitude corresponds to the background which appears
in all FCCS measurements of the spliceosome. By the addition of Prp2, Spp2, and
ATP, the C complex was formed. The cross-correlation amplitude increased from
∼1 % to ∼31 % which indicates that Cwc25 was recruited to the spliceosome during
B* complex formation and was stably bound to the C complex. Further incubation
with Prp16 and ATP led to the formation of the C* complex but not to the release
of Cwc25 from the complex. The cross-correlation amplitude for the C* complex
was slightly reduced to 26 % but was still comparable to the one for the C complex.
The cross-correlation amplitude was also comparable to the one obtained from the
reaction of the C complex with Prp16 and AMP-PNP (column C*+AMP-PNP).
These results showed that Prp16 and its ATP-dependent catalytic activation for
56 3. Results
Figure 24: Binding of Cwc25-Alexa488 to Actwt pre-mRNA. Eluted C complexes
were complemented in solution with Prp16 and Slu7/Prp18. FCCS measurements were
performed upon the addition of ATP, AMP-PNP or without ATP. (Figure also appeared
in the PhD thesis of Peter Odenwälder and Ohrt et al. [84])
the step 2 catalysis are not sucient for the release of Cwc25. Further addition of
Slu7/Prp18 to the C* complexes led to a low cross-correlation amplitude of ∼12 %.
This indicates that Cwc25 dissociated from the complex. A comparable release was
not observed for C complex incubated with Prp16 and Slu7/Prp18 without ATP or
with AMP-PNP.
In conclusion, these results showed that for the release of Cwc25, the ATPase activity
of Prp16 and Slu7/Prp18 are necessary. The addition of only Prp16 is not sucient
for the dissociation of Cwc25 from the spliceosome.
3.2.2 Binding anity of Cwc25 to the B* complex
Initially, the binding of Cwc25 to the B* complex was studied in detail. The bind-
ing anity of Cwc25 to the spliceosome changed drastically from the Bact to the
B* complex (see g. 25). Therefore, the binding constant for Cwc25 to the Bact
and B* complexes was measured. By choosing these two complexes, the binding
anity of Cwc25 immediately before and after catalytic activation by Prp2 could be
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Figure 25: Titration of Bact∆Prp2 complexes and B* complexes to Cwc25-
Alexa488. Cross-correlation amplitudes for the titration of Bact∆Prp2 and B* complexes
to 0.3 nM Cwc25-Alexa488. The data points were tted by a Hill plot and yielded a dis-
sociation constant of Cwc25-Alexa488. (Figure also appeared in the PhD thesis of Peter
Odenwälder and published in Prior et al. [54])
investigated. To measure the binding curves, increasing amounts of the complexes
were added to a xed concentration of Cwc25-Alexa488 of 0.3 nM.
The changes in the cross-correlation amplitude with complex concentration are
shown in gure 25. It was not possible to observe a binding curve of Cwc25 to
the Bact complex because Cwc25 was not bound to this complex. However, a bind-
ing curve was observed for the B* complex (see g. 25). Data points were tted





where y is the cross-correlation amplitude, x the complex concentration, n the Hill
coecient, Kd the binding constant, and C a constant taking into account some
oset in the binding curve. For the tting, n = 1 was assumed to describe a non-
cooperative one-to-one binding behavior. The mean Kd and its error were estimated
by a bootstrapping method taking into account the standard deviation of each data
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point [85]. The t of the Hill equation to the data points of the B* complex yielded
a binding constant of Kd = (0.03 ± 0.01) nM. This low binding constant indicates a
high binding anity of Cwc25 to the complex after the action of Prp2.
These measurements showed on the one hand, that FCCS can be used to monitor
very low binding constants between two interaction partners which have large dif-
ferences in size, i.e. the spliceosome and one small protein. On the other hand,
that the Prp2-dependent rearrangements generated a high-anity binding site for
Cwc25. To obtain more insights into the mechanisms of Cwc25's release, further
experiments on mutated pre-mRNAs were necessary. These are described in the
following sections.
3.2.3 Binding of Cwc25-Alexa488 to the ActACAC pre-mRNA
Measurements on spliceosomes assembled on actin pre-mRNA with a mutated 3'SS
were performed, to determine if the dissociation of Cwc25 necessitates the second
catalytic step. The used actin pre-mRNA carried an ACAC sequence instead of an
AGAG one on the 3'SS (ActACAC pre-mRNA). Due to this mutation, the spliceo-
some cannot undergo the second catalytic step.
The results of FCCS measurements on spliceosomes assembled on ActACAC pre-
mRNA are shown in gure 26. Comparable to the results for the measurements on
spliceosomes assembled on Actwt pre-mRNA, the cross-correlation amplitude was
higher for the C (g. 26, column C, ∼22 %) than for the Bact complex (∼1 %). Cwc25
was bound to the C complex after the action of Prp2/Spp2. Whereas addition
of Prp16 led to a small decrease in the cross-correlation amplitude to 20 %, the
overall amplitude remained high suggesting that Cwc25 was still bound. Further
addition of Slu7/Prp18 and ATP led to the release of Cwc25, shown by a reduced
cross-correlation amplitude of ∼4 %. Measurements on C complexes incubated with
Prp16 and Slu7/Prp18 with AMP-PCP or without ATP showed no signicant change
in the cross-correlation amplitude which remained between 18 % and 19 % in all
cases. A release of Cwc25 was only observed for complexes incubated with Prp16,
Slu7/Prp18, and ATP (g. 26, column C2nd).
These data showed that Cwc25 is released from the spliceosome if the second cat-
alytic step is blocked and Slu7/Prp18 is required for the dissociation of Cwc25.
As a control experiment, the products of the splicing reaction were analyzed by
denaturing gel electrophoresis (these experiments were performed by the lab of
Prof. Lührmann) and aliquots from the same reactions that had been used for the
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Figure 26: Binding of Cwc25-Alexa488 to ActACAC 3'SS mutated pre-mRNA.
Eluted C complexes were complemented in solution with Prp16 and Slu7/Prp18. FCCS
measurements were performed upon the addition of ATP, AMP-PCP, or without ATP.
(Figure also appeared in the PhD thesis of Peter Odenwälder and in Ohrt et al. [84])
FCCS measurements were taken. The samples were loaded on a gel and visualized
by autoradiography. The splicing products, i.e. the 5'exon, the intron-3'exon, the
intron, and both exons, are visualized by bands. The electrophoresis experiment
showed that the second catalytic step did not occur because splicing products were
not detected (see g. 27, left site). In contrast, a comparable gel of the spliceosomes
assembled on Actwt pre-mRNA showed that the rst as well as the second catalytic
step proceed which can be concluded from the presence of bands corresponding to
the splicing products (see g. 27, right site).
The measurements on Act pre-mRNA and ActACAC pre-mRNA showed that
Slu7/Prp18 is required for the displacement of Cwc25 from the spliceosome irre-
spective of whether or not the second step occurs. The used pre-mRNA has a long
distance between the branch site and the 3'SS of 38 nucleotides. For this reason,
Slu7/Prp18 is essential to bind the 3'SS eciently into the step 2 active site [61]. It
was shown by crosslinking experiments that Slu7 directly contacts mutant 3'SS [61]
and may also facilitate docking of the 3'SS ACAC mutant. It is possible that the
actual docking of the 3'SS to the step 2 active site induces the release of Cwc25 from
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Figure 27: Splicing assay of spliceosomes assembled on ActACAC pre-mRNA
and Actwt pre-mRNA. ActACAC and Actwt pre-mRNAs were extracted from spliceo-
somal complexes obtained as described above each lane, separated by denaturing PAGE,
and visualized by autoradiography. The positions of the pre-mRNAs and the splicing inter-
mediates are indicated on the right. Asterisks: uncharacterized pre-mRNA bands. (Figure
also appeared in Ohrt et al. [84])
the spliceosome and not the recruitment of Slu7/Prp18 to the spliceosome per se.
To test this hypothesis, Act pre-mRNA with a shorter distance between the branch
site and the 3'SS was used. This experiment is described in the following section.
3.2.4 Binding of Cwc25-Alexa488 to the Act7wt pre-mRNA
The requirement of step 2 factors for the second catalytic step is less strict if the
distance between the branch site and the 3'SS is short [65] [66] [86]. Act7 pre-mRNA
with a distance of seven nucleotides between the BS and 3'SS was used to investigate
the binding behavior of Cwc25 for pre-mRNAs with short distances. The results of
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Figure 28: Binding of Cwc25-Alexa488 to Act7wt pre-mRNA. Eluted C complexes
were complemented in solution with Prp16 and Slu7/Prp18. FCCS measurements were
performed upon the addition of ATP, AMP-PCP, or without ATP. (Figure also appeared
in the PhD thesis of Peter Odenwälder and in Ohrt et al. [84])
FCCS measurements with Act7 pre-mRNA are shown in gure 28. Comparable to
the previous results, Cwc25 was bound to the C complex shown by a high cross-
correlation amplitude of ∼23 %. Further incubation of C complexes with Prp16 and
ATP led to a lower cross-correlation amplitude of 12.5 % (see g. 28, column C
and C*) which indicates that a high amount of Cwc25 was released. Incubation of
C complexes with Prp16, Slu7/Prp18, and ATP induced further release of Cwc25
indicated by a decrease in cross-correlation amplitude to ∼7 %. Similar to the
previous results, incubation with AMP-PCP or without ATP did not change the
cross-correlation amplitudes which were about 20 % to 22 %. This suggests that
Cwc25 does not dissociate from the spliceosome.
To investigate the factor requirements for step 2 catalysis for spliceosomes assem-
bled on Act7 pre-mRNA, anity-puried Act7-Bact complexes were eluted from the
matrix, complemented with recombinant proteins, and analyzed by denaturing gel
electrophoresis (see g. 29).
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Figure 29: Factor requirements for the second catalytic step of complexes
assembled on Act7 pre-mRNA. Bact complexes were complemented with Prp2, Spp2,
Cwc25, and ATP (lane 1). Complexes were additionally complemented with Prp16 (lane
2), Slu7/Prp18 (lane 4), and Prp22 (lane 5). (Figure also appeared in the PhD thesis of
Peter Odenwälder and in Ohrt et al. [84])
Incubation of Act7-Bact complexes with Prp2, Spp2, Cwc25, and ATP yielded e-
cient step 1 intermediates (see lane 1 in g. 29). The addition of Prp16 led to the
formation of step 2 splicing products (lane 2). Upon further addition of Slu7 and
Prp18, the amount of splicing products, i.e. mRNA and intron lariat, was increased
(lane 4). The addition of Prp22 had no eect on the amount of splicing products
(lane 5).
These data showed that for a pre-mRNA with a short distance between BS and
3'SS, incubation of C complexes with Prp16 and ATP is sucient for the release
of a small amount of Cwc25 from the spliceosome and for catalysis of the second
step. Further addition of Slu7/Prp18 led to the dissociation of more Cwc25 and to
a higher amount of splicing products.
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3.2.5 Binding of Cwc25-Alexa488 to the Act7ACAC mutated
pre-mRNA
In the next experiments, spliceosomes were assembled on Act7ACAC pre-mRNA.
This pre-mRNA has a distance of seven nucleotides between BS and 3'SS and a
mutation on the 3'SS. Due to this mutation, the second catalytic step is blocked.
With this experiment it can be tested if the second catalytic step is a prerequisite
for the dissociation of Cwc25 from spliceosomes assembled on Act7 pre-mRNA.
Figure 30: Binding of Cwc25-Alexa488 to Act7ACAC 3'SS mutated pre-
mRNA. Eluted C complexes were complemented in solution with Prp16 and Slu7/Prp18.
FCCS measurements were performed upon the addition of ATP, AMP-PCP, or without
ATP. (Figure also appeared in the PhD thesis of Peter Odenwälder and in Ohrt et al. [84])
The measured cross-correlation amplitudes are shown in gure 30 and were similar
to the cross-correlation amplitudes observed for spliceosomes assembled on Act7
pre-mRNA. After incubation of the C complex with Prp16 and ATP, the cross-
correlation amplitude was decreased from ∼27 % to ∼17 %. A further decrease to
∼10 % was observed for the C complex incubated with Prp16, Slu7/Prp18, and ATP.
Similar to the previous measurements on dierent pre-mRNAs, ATP was necessary
for the release of Cwc25. Incubation with AMP-PCP or without ATP led to further
binding of Cwc25 to the spliceosome.
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The measurements on spliceosomes assembled on Act7ACAC pre-mRNA showed
that Cwc25 is released from the spliceosome by the action of Prp16. Further release
is initiated by the action of Slu7/Prp18. The second catalytic step per se is again
not a condition for the dissociation of Cwc25.
In summary, the results of all measurements on spliceosomes assembled on Act pre-
mRNA, ActACAC pre-mRNA, Act7 pre-mRNA, and Act7ACAC pre-mRNA showed
that the second catalytic step is not a cause for the release of Cwc25. The distance
between the branch site and 3'SS is important and can change the conditions for
Cwc25's release. The results are consistent with the assumption that the docking of
the 3'SS to the active step 2 site is sucient for the release of Cwc25.
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3.3 Functionality testing of Slu7-eGFP and Prp16-eGFP
The previous FCCS measurements showed that Prp16 and Slu7/Prp18 are involved
in the dissociation process of Cwc25. The stage of the spliceosome at which Prp16
and Slu7/Prp18 are recruited to the spliceosome and their binding sites are poorly
understood. To clarify these ambiguities, the binding and dissociation of Prp16-
eGFP and Slu7-eGFP/Prp18 to the dierent stages of the spliceosome were investi-
gated. For the experiments, a fusion protein of Slu7 with eGFP and a fusion protein
of Prp16 with eGFP were expressed in yeast cells. Before starting with the FCCS
experiments, the functionality of Slu7-eGFP and Prp16-eGFP was tested by an in
vitro splicing assay which is shown in gure 31.
Figure 31: Functional assay for testing the functionality of Slu7-eGFP and
Prp16-eGFP. Bact complexes assembled on Actwt pre-mRNA (lane 1) were complemented
with Prp2, Spp2, ATP, and Cwc25 (lane 2). Complexes were additionally complemented
with Slu7-eGFP (lane 4), Prp16-eGFP (lane 6), or Prp16, Slu7, and Prp18 (lanes 3 and
5). (Figure also appeared in Ohrt et al. [84])
The splicing assay showed the splicing products for spliceosomes complemented with
Slu7-eGFP (lane 4) instead of Slu7 (lane 3) and Prp16-eGFP (lane 6) instead of
Prp16 (lane 5). The bands were similar for the four dierent compositions and both
proteins are functional if they carry the uorescent protein eGFP.
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3.4 FCCS measurements for investigating the binding of Slu7-
eGFP
Previous immunoprecipitation studies suggested that Slu7 binds stably to the spliceo-
some after the Prp16-mediated remodeling of the spliceosome [61,65]. However, it is
unclear if Slu7 already has a binding site at an earlier stage of the splice cycle. To
clarify this, the cross-correlation amplitudes for Slu7-eGFP bound to the Bact, B*,
C, and C* complex at low salt (75 mM KCl) and high salt (150 mM KCl) condi-
tions were measured. The dierent complexes were reconstituted by supplementing
anity-puried Bact on the amylose anity matrix with recombinant splicing fac-
tors. Then, the complexes were incubated with Slu7-eGFP and Prp18, and without
Prp18 and washed with GK75 buer respectively GK150 buer. In the end, the
complexes were eluted from the matrices with maltose and measured with FCCS.
The results are shown in gure 32.
First, the cross-correlation amplitudes for complexes which were washed with a low
salt buer containing 75 mM KCl were measured. The observed cross-correlation
amplitude for Bact complexes incubated with Slu7 and Prp18 was low (∼3 %) and
Slu7-eGFP was not bound to the Bact complex. After the addition of Prp2/Spp2,
the cross-correlation amplitude was increased up to ∼22 % and Slu7 was bound
eciently to B* complexes (see g. 32, column 2).
In order to form the C complex, the Bact complex was supplemented with Prp2/Spp2,
Cwc25, and ATP. Further addition of Prp16 led to the formation of the C* complex.
The addition of Slu7 and Prp18 to the C* complex then resulted in a post-catalytic
(PC) complex. The obtained cross-correlation amplitudes for the C and C*/PC
complex were comparably high (18 % - 19 %).
These data showed that Slu7 was bound to the spliceosome at an early stage. A
binding site for Slu7/Prp18 is already created when the spliceosome is catalytically
activated by Prp2, Spp2, and ATP. Without Prp18, the measured cross-correlation
amplitude was low (∼2 %) and Slu7 is only bound to the spliceosome in the presence
of Prp18. This result is consistent with the assumption that Slu7 and Prp18 bind
as a heterodimer to the spliceosome.
In the next step, the spliceosomes were washed with GK150 buer with 150 mM
KCl instead of 75 mM KCl. The resulting cross-correlation amplitudes are shown in
gure 32 on the right side. In comparison to complexes washed with 75 mM KCl,
the cross-correlation amplitudes for Bact, B*, and C complexes were low (∼1 %).
Slu7 was not bound to these complexes. The cross-correlation amplitude was high
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Figure 32: Binding behavior of Slu7-eGFP to the spliceosome. Cross-correlation
amplitudes for the binding of Slu7-eGFP to the Bact, B*, C, and C*/PC complexes are
shown. C*/PC indicates that upon Slu7/Prp18 binding to the C* complex, the latter
is transformed into the post-catalytic complex (PC). Measurements were performed with
75 mM KCl and 150 mM KCl. (Figure also published in Ohrt et al. [84])
(∼16 %) when the Bact complex was incubated with Prp2/Spp2, Cwc25, Prp16,
Prp18, ATP, and Slu7 .
For testing if C complexes containing Slu7/Prp18 catalyze the second catalytic step,
a denaturing PAGE was performed. Reconstituted C complexes were incubated on
the matrix with Slu7/Prp18 at 75 mM KCl and 150 mM KCl. Complexes were
washed with GK75 buer and GK150 buer, respectively. Then they were eluted
from the matrix in GK75 buer and mock-treated or incubated with Prp16. After
incubation, the RNAs were extracted and separated by denaturing PAGE. The
RNAs from mock-treated complexes are shown in lanes 2 and 5 in gure 33 and
RNAs from complexes incubated with Prp16 plus ATP in lanes 3 and 6. This
experiment shows that C complexes which were washed with GK75 buer and thus
have a low-anity binding site for Slu7/Prp18, catalyze the second step eciently
if Prp16 and ATP are present (see lane 3 in g. 33). Splicing products were not
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Figure 33: Denaturing PAGE with C complexes. Denaturing PAGE of extracted
RNAs of C complexes which were washed with buers containing 75 or 150 mM KCl, eluted
from the matrix, and mock-treated or incubated with Prp16 plus ATP. Using ImageQuant
software, the intensities of the intermediate and mRNA product signals were quantied.
The signals in lane 3 were used as 100 %. (Figure also appeared in Ohrt et al. [84])
detected for the Bact complex or the C complex without Prp16 plus ATP.
If the C complex was washed with GK150 buer, only low amounts of mRNA prod-
ucts were detected (see lane 6 in g. 33). By quantifying the signal intensities of the
intermediates and mRNA products by using the ImageQuant software (Molecular
Dynamics) and setting the signals in lane 3 as 100 %, the amounts of mRNA prod-
ucts in lane 6 can be calculated. C complexes washed with GK150 buer yielded
only 40 % of the intron-lariat 3' exon, 28 % of the intron-lariat, and 23 % of mRNA.
These measurements showed that the binding anity of Slu7/Prp18 to the Bact, B*,
and C complex is low because the observed cross-correlation amplitudes were low
at harsh conditions, i.e. 150 mM KCl. Due to the high cross-correlation amplitude
obtained for C* complexes at low and high salt concentrations, the low-anity
binding site is converted into a high-anity binding site for the C*/PC complex.
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The conversion into a high-anity binding site is done by the Prp16 ATP-dependent
remodeling of the C complex into the C* complex.
The data obtained from the electrophoresis experiment suggest that Slu7/Prp18 can
facilitate the second catalytic step if it is bound to its low-anity binding site in
the C complex. This indicates that the low-anity binding site is the functionally
relevant site.
3.5 FCCS measurements for investigating the binding of Prp16-
eGFP
It was shown that Prp16 may act during step 1 of splicing [87,88]. To prove this
assumption, FCCS measurements with Prp16 similar to the experiments with Slu7
were performed. For the experiments, Prp16-eGFP was overexpressed in yeast cells
and subsequently puried as described in the method section. The binding behavior
of Prp16-eGFP to the Bact, B*, C*, and C*/PC complex at low salt concentration
(75 mM KCl) and at high salt concentration (150 mM KCl) was observed.
First, the binding of Prp16 to the spliceosomal complexes at low salt concentration
was studied. The obtained data are shown on the left side in gure 34. For the Bact
complex, a cross-correlation amplitude of ∼7 % was measured (see g. 34, column
1) which indicates that Prp16 was not bound to this complex. After the remodeling
of the spliceosome activated by Prp2, Prp16 was bound to the B* complex which
could be seen by a high cross-correlation amplitude of ∼25 %. A comparable cross-
correlation amplitude was observed for the C* complex after the addition of Cwc25.
After further addition of Slu7/Prp18 and the conversion of the C* complex into the
C*/PC complex by the action of Prp16 and ATP, the cross-correlation amplitude
remained high (∼27 %). These results indicate that Prp16 is bound to the B*, C*,
and C*/PC complex.
When the experiment was carried out at high salt concentration (150 mM KCl), the
cross-correlation amplitude for the Bact complex remained low (∼3 %) (see g. 34,
right side). For the B* complex, the observed cross-correlation amplitude of ∼15 %
was lower than the one for the B* complex at 75 mM KCl (∼25 %). However, the
cross-correlation amplitude was still higher than for the Bact complex and thereby
higher than the background. The measured cross-correlation amplitude for the C*
complex was high (∼25 %) and similar to the observed cross-correlation amplitude for
the C* complex at low salt concentration. From the high cross-correlation amplitude
even at harsh conditions it could be concluded that Prp16 has a high binding anity
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Figure 34: Binding behavior of Prp16-eGFP to the spliceosome. Cross-correlation
amplitudes for the binding of Prp16-eGFP to the Bact, B*, C*, and C*/PC complexes are
shown. C*/PC indicates that upon Slu7/Prp18 binding to the C* complex, the latter
is transformed into the post-catalytic complex (PC). Measurements were performed with
75mM KCl and 150mM KCl. (Figure also published in Ohrt et al. [84])
to the C* complex. For the C*/PC complex, the cross-correlation amplitude was
reduced to ∼15 %.
In summary, Prp16 has already a binding site on the B* complex. The anity of
Prp16 is more salt resistant compared to Slu7/Prp18 and Prp16 is released from the
spliceosome after the second catalytic step has proceed.
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3.6 Discrimination of Prp16's and Slu7's binding site on the
B* spliceosome
The measurements on Slu7-eGFP and Prp16-eGFP showed that both proteins have
binding sites on the B* complex. It is still unclear if they have the same binding
site, dierent binding sites, or partially overlapping sites. To answer this question,
FCCS was used to monitor the binding of Prp16-eGFP to the B* complex after the
addition of dierent amounts of unlabeled Prp16 and unlabeled Slu7/Prp18. The
observed cross-correlation amplitudes are shown in gure 35.
By increasing the amount of unlabeled Prp16 (1:1, 1:3, 1:7 of Prp16-eGFP to Prp16),
the cross-correlation amplitudes were reduced from 26 % to 13 % (see g. 35, col-
umn 1-4). By increasing the amount of unlabeled Slu7/Prp18, the cross-correlation
amplitudes remained constant at ∼25 %. This corresponds to a high binding anity
of Prp16-eGFP to the B* complex.
Figure 35: Competition of Prp16-eGFPs binding site with the one for
Slu7/Prp18. Cross-correlation amplitudes for the binding of Prp16-eGFP to the B*
spliceosome after the addition of unlabeled Prp16 or Slu7/Prp18 in dierent amounts.
The amount of unlabeled Prp16 or Slu7/Prp18 was increased in the ratio of 1:1, 1:3, and
1:7 of Prp16-eGFP to Prp16 or Slu7/Prp18. (Figure also published in Ohrt et al. [84])
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In the next step, the complementary experiment was performed by monitoring the
binding behavior of Slu7-eGFP after the addition of increasing amounts of unlabeled
Slu7/Prp18 or unlabeled Prp16. The results are shown in gure 36.
Comparable to the experiment with Prp16, the cross-correlation amplitude was de-
creased after the addition of unlabeled Slu7/Prp18 to Slu7-eGFP from 17% to 6%
(1:1, 1:3, 1:7 of Slu7-eGFP to Slu7/Prp18). The cross-correlation amplitudes re-
mained constant after the addition of unlabeled Prp16 at 15 %.
The data of both experiments indicate that Prp16 and Slu7/Prp18 have dier-
ent binding sites on the catalytically activated B* complex. Otherwise, the cross-
correlation amplitude of Slu7-eGFP to the B* complex should show a decrease after
the addition of Prp16 and vice versa.
Figure 36: Competition of Slu7-eGFPs binding site with the one for Prp16.
Cross-correlation amplitudes for the binding of Slu7-eGFP/Prp18 to the B* spliceosome
after the addition of Prp18 and dierent amounts of unlabeled Prp16 or Slu7/Prp18. The
amount of unlabeled Slu7/Prp18 was increased in the ratio of 1:1, 1:3, and 1:7 of Slu7-eGFP
to Prp16 or Slu7/Prp18.
(Figure also published in Ohrt et al. [84])
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4 Discussion
4.1 FCCS studies on the spliceosome
FCCS is a method to study interactions of various molecules such as proteins, lipids,
or carbohydrates, in solution with the need of being uorescent either by carrying
already a natural uorescent center or by a uorescent tag attached to it. In this
study, FCCS was used to monitor binding reactions and interactions of proteins to
the spliceosome, a huge macromolecular complex.
The spliceosome, added proteins and reaction conditions have to fulll several cri-
teria during the experiment. First, the spliceosome needs to be stable over the
preparation and measurement time (3 hours), and degradation and aggregation of
the complexes have to be avoided as they can distort the correlation curves. Second,
it has to be tested if the spliceosomes are stable at the nanomolar concentrations.
Nanomolar concentrations are necessary because FCCS is a single molecule method.
The feasibility of FCCS for studying dynamics of the spliceosomes was investigated.
The temporal stability was tested with puried labeled spliceosomes carrying an
additional uorescently labeled Cwc22 protein over a time range of 3 hours. Cwc22
was used to investigate the temporal stability because it is not a core component
of the spliceosome [37]. The cross-correlation amplitudes for Cwc22's binding to the
Bact complex at time point zero and after 3 hours were comparably high (see g. 20).
The shape of the correlation curves and their perfect ts showed that the sample
did not aggregate or degrade over 3 hours (see g. 21). The measurements showed
further that no additional uorescent background is generated by the spliceosome
or the used buers. In addition, the uorescent signals were constant over the
measurement time and no amplitude due to aggregates could be observed in the
count rates (data not shown).
The puried spliceosomal complexes have to behave in the same way in all FCCS
measurements, and the addition of further proteins should not induce further ag-
gregation of the complexes. These criteria were investigated by using Snu114-eGFP
because Snu114 is a stable component during the activation and catalytic steps of
the spliceosome. The observed cross-correlation amplitudes were constant at the
dierent maturation steps of the spliceosome (see g. 22). Snu114-eGFP remained
stably attached to all complexes as observed for native Snu114 proteins in previous
studies [82] and no dissociation of proteins due to the necessary low concentrations
(∼1 nM for single molecule measurements) was observed. For inducing the activation
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and catalytic steps, several proteins were added to the solution. These proteins in-
duced no aggregation of complexes and had no further disturbing eects because the
cross-correlation curves were all well-dened (data not shown). The measurements
showed further that the uorescent labels did not induce artefacts in the FCCS
measurements because Snu114-eGFP and native Snu114 showed a similar binding
behavior.
To test whether the uorescent labels have an eect on the spliceosome behavior
and thereby inducing artefacts, reconstitution assays where performed with extracts
from tagged yeast strains or tested in reconstituted splicing assays, e.g. Prp16-eGFP
and Slu7-eGFP (g. 31). The reconstitution assay showed that the labeled proteins
were just as functional as native proteins and the catalysis of the spliceosome was
not inuenced by the uorophores.
To investigate the suitability of FCCS for observing small changes in the binding
anity of a protein, the measurement errors have to be considered. For example,
measurements on Snu114-eGFP and the Bact∆Prp2, B*, C, C*, and C2nd complex
yielded high cross-correlation amplitudes of around 57 % (see g. 22). The standard
deviations for the data points were between 0.2 % to 1.4 % and comparable to the
cross-correlation amplitudes quite low. The cross-correlation amplitudes for Snu114,
which is bound to all complexes, only diered in a range of 2 %. Therefore, FCCS can
be used for monitoring small changes in the binding of a protein to the spliceosome.
4.1.1 Information about binding anities given by FCCS
Accurately describing protein function and activity is still dicult. FCCS oers
a possibility for determining protein anities with high precision and is thus a
promising tool to tackle this problem. In most studies, the binding interactions
between small molecules were investigated [20,22], but no study monitored the binding
constant in a macromolecular complex in which more than 80 proteins are involved
like the spliceosomal Bact or B* complex. Here, FCCS was used for the rst time to
determine a binding constant for the spliceosome in equilibrium and in a nanomolar
to picomolar range. The binding anity between Cwc25, a small protein, and the
Bact and B* complex were determined. These complexes were chosen because FCCS
measurements showed that Cwc25 does not bind eciently to the spliceosome before
the catalytic activation by Prp2 but after the activation.
In the measurements, the standard deviations of several data points were high com-
pared to the cross-correlation amplitude itself (see g. 25). For 0.01 nM of the B*
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complex, a cross-correlation amplitude of 3.2 % with a standard deviation of 2.8 %
was measured. The standard deviations of other data points were low, e.g. a cross-
correlation amplitude of 11.2 % with a standard deviation of 0.2 % was measured
for 0.4 nM B* complex. These dierent and partly high standard deviations can in-
uence the tting procedure, but were taken into account by using a bootstrapping
method, which considers the dierent standard deviations of each data point. The
Hill equation t together with the bootstrapping method yielded a binding constant
of Kd = (0.03 ± 0.01) nM. The error of the binding constant is quite high compared
to the binding constant itself because the error is inuenced by the relatively high
standard deviations of particular data points. However, even considering the large
error, the binding constant is still low and reects a strong binding site for Cwc25 on
the B* complex. The relatively large error of the binding constant is also caused by
the complexity of the preparation method and the complexity of the sample itself.
Additionally, measuring at only picomolar concentration further increases the pipet-
ting error and errors in serial dilutions. Despite the relatively large errors, FCCS can
be reliably used to determine binding constants. This was done here for the rst
time at only picomolar concentrations which is extremely benecial for biological
samples as preparing them in large amounts is very challenging.
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4.2 Information obtained by FCCS about the recruitment
and release of spliceosomal factors
4.2.1 Binding behavior of the step 1 factor Cwc25
FCCS was used to understand the dynamic nature of the spliceosome during its
catalytic activation.
Cwc25's binding and release was investigated at the dierent maturation steps of
the spliceosome with a wildtype pre-mRNA. It was observed that Cwc25 was not
bound to the Bact complex shown by a low cross-correlation amplitude which was
comparable to the background. The measurement of the C complex yielded a much
higher cross-correlation amplitude than for the Bact complex (see g. 24). Thus, by
the action of the helicase Prp2 and its cofactor Spp2, a strong binding site for Cwc25
is formed in the B* complex. The formation of the binding site was also shown by
the binding constant measurement on the Bact and B* complex (see g. 25) which
yielded for Cwc25-Alexa488 a binding constant of 30 pM to the B* complex (see g
25). This value reects a strong binding of Cwc25-Alexa488 to the B* complex. In
contrast to the high binding anity to the B* complex, it was not possible to detect
binding of Cwc25-Alexa488 to the Bact complex. This is in agreement with previous
mass spectrometry data of puried spliceosomes showing no Cwc25 at Bact level
and higher values at C complex [84] [37]. By Prp2s action, a binding site for Cwc25 is
generated.
Further incubation of the C complex with Prp16 and ATP yielded the C* complex.
The cross-correlation amplitude was slightly decreased in comparison to the one
for the C complex, but no signicant change within the error bars for both com-
plexes was observed. The control experiment with Prp16 and AMP-PNP yielded
a cross-correlation amplitude that was comparable to the one obtained for C com-
plexes. This indicates that Prp16 and its ATP-dependent catalytic activation of the
spliceosome for step 2 catalysis are not sucient to release Cwc25 under physiolog-
ical conditions. This measurement showed a dierent behavior than the study of
Tseng et al., in which Cwc25 is released from the spliceosome after the action of
Prp16 solely [69].
Supplementation of the C* complex with Slu7/Prp18 led to the formation of the
C2nd complex and resulted in the signicant release of Cwc25. As negative controls
for the ATP-dependent action of Prp16, experiments with AMP-PNP instead of ATP
or without ATP were performed. In the absence of ATP, a decrease comparable to
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the one for the C2nd complex formation could not be observed. To proof that Prp16
without ATP hydrolysis is not able to form the catalytic center for step 2 catalysis,
the measurement was performed in the presence of AMP-PNP (a non-hydrolysable
ATP analog). Again, the cross-correlation amplitude remained at a high level and no
release of Cwc25 could be observed. This indicates that in both cases, i.e. absence
of ATP and presence of AMP-PNP, the C* complex formation and thereby also the
C2nd complex formation were inhibited.
The measurements on complexes supplemented on Actwt pre-mRNA showed that
the ATPase activity of Prp16 and Slu7/Prp18 are necessary for the dissociation of
Cwc25 from the spliceosome. However, it is unclear if the binding of Slu7/Prp18,
the second catalytic step, or the docking of the 3'SS into the catalytic center is
responsible for Cwc25s dissociation. To determine if the 2nd catalytic step or the
docking of the 3'SS induce Cwc25's release, spliceosomes were assembled on Ac-
tACAC pre-mRNA which is incapable of undergoing the second catalytic step due
to the mutation in the 3'SS. The results of these measurements were comparable
to the results of the FCCS measurements on complexes assembled on Actwt pre-
mRNAs (see g. 26) and indicate that even when the spliceosome cannot undergo
the second catalytic step, Slu7/Prp18 and the activity of Prp16 are necessary for
the release of Cwc25. The FCCS experiments on Actwt pre-mRNA and ActACAC
pre-mRNA suggest that the binding of Slu7/Prp18 to the spliceosome or a confor-
mational change induced by their binding directly displaces Cwc25 and not the step
2 catalysis.
To clarify the role of the 3'SS in the release of Cwc25, experiments with spliceosomes
assembled on Act7 pre-mRNA were performed. Previous studies showed that the
requirement for step 2 factors is less strict if the distance between the branch site
and the 3'SS is short [65] [66] [86]. An Act7 pre-mRNA with a short distance of seven
nucleotides between the BS and 3'SS was used to investigate the binding behavior
of Cwc25. Electrophoresis experiments showed that step 2 catalysis of spliceosomes
assembled on Act7 pre-mRNA was catalyzed in the absence of Slu7/Prp18, but
the step 2 eciency was increased twofold in the presence of this heterodimer (see
g. 29). However, only Prp16 and ATP are required for exon ligation and not Slu7
or Prp18. Previous studies showed that despite single or double depletions of Slu7,
Prp18, or Prp22 from splicing extracts the second catalytic step proceeds [65] [66] [64] [56].
With the used reconstitution assays, it could be shown that the ATP-dependent
action of Prp16 is sucient for the formation of a functional step 2 site. Exon ligation
occurs without Slu7, Prp18, and Prp22. This indicates that for pre-mRNAs with
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a short distance between the BS and 3'SS, diusion brings the 3'SS to its docking
position in the catalytic center and no further help by Slu7/Prp18 is necessary. The
explanation for the fact that the addition of Slu7/Prp18 increases the eciency
of the second step could be that the docking of the 3'SS is more ecient in the
presence of Slu7/Prp18. This suggests that the action of Slu7/Prp18 alters the
conformation of the spliceosome. For pre-mRNAs with a longer distance between
BS and 3'SS, the docking of the 3'SS only by diusion through space is inecient and
may be prevented by secondary structures in the pre-mRNA [89]. Then, Slu7/Prp18
are essential for the second catalytic step and the ecient docking of the 3'SS in
the catalytic center. The results with Act7 pre-mRNA showed that the 3'SS is
recognized and bound by the step 2 active site without Slu7, Prp18, and Prp22. A
previous study demonstrated that in the absence of the step 2 factors the spliced
Act7 mRNA is stably bound to the spliceosome of the second step and dissociates
only by the action of Prp22 [90]. Loop 1 of the U5 snRNA and Prp8 are the known
spliceosomal components that are involved in the recognition and binding of the
3'SS [91] [92] [93] [94] [95]. The function of Slu7/Prp18 could be to help to stabilize the
interaction between the 3'SS and the active site. The stabilization may occur directly
or indirectly via Prp8, particularly if the interaction of the 3'SS is weak [96].
In the FCCS experiments on spliceosomes assembled on Act7 pre-mRNA, the cross-
correlation amplitude for the C complex incubated with Prp16 was reduced and
Cwc25 dissociated from the spliceosome in the absence of Slu7/Prp18. The amount
of released Cwc25 proteins was increased upon incubation with Prp16, Slu7/Prp18,
and ATP (see g. 28). This result indicates the following mechanism: First, local
rearrangement of the catalytic center from the step 1 to step 2 conformation was
induced by the ATP-dependent action of Prp16. This structural change decreases
the binding anity of Cwc25 in the spliceosome but Cwc25 is still bound. By the
docking of the 3'SS into the active center, Cwc25 is displaced from the spliceosome
via an additional conformational change at the catalytic center.
To check if the stable docking of the 3'SS and not the process of the second catalytic
step is the trigger for Cwc25s release, experiments with spliceosomes assembled on
Act7ACAC pre-mRNA were conducted. The measurements on Act7 pre-mRNA
and Act7ACAC pre-mRNA showed comparable results (see g. 30). Even if the
spliceosome could not undergo the second catalytic step due to the ACAC mutation
in the 3'SS, a certain amount of Cwc25 dissociated from the spliceosome after the
activity of Prp16. Further incubation with Slu7/Prp18 then led to further release of
Cwc25 from the spliceosome. These measurements showed that the stable docking
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of the 3'SS into the catalytic center is the prerequisite for Cwc25's dissociation and
not a productive catalysis of the second step. This model is in agreement with
the results of previous studies in which the second catalytic step was inhibited by
mutations in the 3'SS [61] [46]. These mutations were nevertheless bound by Slu7 and
potentially at the catalytic center of the spliceosome.
In a model of the processes, the binding of Slu7/Prp18 to Actwt C* spliceosomes
leads indirectly to the release of Cwc25. The primary task of Slu7/Prp18 is eciently
docking of the 3'SS into the catalytic center for the second step. A possible further
function of Slu7/Prp18 is the triggering of a conformational change in the catalytic
center that stabilizes the step 2 conformation and destabilizes the binding of Cwc25
in the catalytic center. The FCCS measurements on the C complexes assembled on
Act7 pre-mRNA showed that this possible function of Slu7/Prp8 is not a critical
one.
To conclude, the results indicate that the second catalytic step is not the trigger
for the release of Cwc25 from the spliceosome. The FCCS measurements suggest
that the activity of Prp16 is a prerequisite for the release of Cwc25. For complexes
assembled on Actwt pre-mRNA, the action of Slu7/Prp18 leads to the dissociation
of Cwc25. The distance between BS and 3'SS strongly inuences the requirements
for Cwc25s release. If the distance is short, the 3'SS can assume a position close
to the active site. Upon ATP hydrolysis by Prp16, the spliceosome is rearranged
with the 3'SS still in the catalytic center. In this case, the 3'SS is close enough
to the catalytic center and the step 2 active site without further stabilization by
Slu7/Prp18. The activity of Prp16 alone and the docking of the 3'SS into the active
site is sucient for the dissociation of Cwc25. Further addition of Slu7/Prp18 then
stabilizes the step 2 conformation, facilitates the docking event, and thereby the
further release of Cwc25 from the spliceosome.
A previous study of Tseng et al. showed a dierent behavior. Using immunopre-
cipitation experiments, they monitored that Cwc25 is displaced after the action of
Prp16 alone. They performed experiments in the presence and in the absence of
ATP and showed that the function of Prp16 is ATP dependent [69]. The experiments
were performed at high salt concentrations of 200 mM KCl. It was shown by sev-
eral FCCS experiments in this study that the binding anity of one protein varies
for dierent salt concentrations. Higher salt concentrations correspond to harsher
conditions for the binding of a protein. At 200 mM KCl, Cwc25 is more readily
displaced from the spliceosome. Our experiments were performed at lower and more
physiological salt concentrations of 75 mM KCl, which is a more gentle condition
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for the spliceosome. Another problem in the study of Tseng et al. is a possible
contamination with Slu7/Prp18 due to their experimental conditions. The presence
of this heterodimer can severely inuence and falsify their results.
4.2.2 Binding behavior of Slu7/Prp18 and Prp16
Currently, it is poorly understood at which moment the step 2 factors Slu7/Prp18
and Prp16 are recruited to the spliceosome. Therefore, FCCS measurements with
Slu7-eGFP and Prp16-eGFP on the Bact, B*, C, and C* complex were performed.
Experiments at low (75 mM KCl) and at high salt concentrations (150 mM KCl)
were conducted to gain information about whether the binding is weak - indicated
by reduced binding at 150 mM - or strong - indicated by comparable binding levels
at both concentrations.
At 75 mM KCl, a high cross-correlation amplitude for Slu7-eGFP from the B* to
the post catalytic (PC) spliceosome could be observed but a low cross-correlation
amplitude for Bact complexes (see g. 32). When the salt concentration was in-
creased to 150 mM KCl, Slu7-eGFP remained only stable at C*/PC but not at the
previous steps like B* and C, shown by low cross-correlation amplitudes which were
comparable to the background. The binding strength of Slu7 to these complexes is
weak, because the binding which is present at low salt concentration is disrupted
at harsher conditions. In contrast, the observed cross-correlation amplitude for the
C*/PC complex was high at both conditions demonstrating that the binding of Slu7
to this latter complex appears to be stronger.
As a control of the functionality of the assay, it was investigated if Slu7 can bind
without Prp18 to the spliceosome. For complexes supplemented with Slu7 but with-
out Prp18 at 75 mM KCl, a low cross-correlation amplitude was observed. This
result indicated that Slu7 can only bind to the spliceosome in the presence of Prp18.
This is in agreement with earlier ndings which showed that both proteins are only
functionally active as a heterodimer [86] [56] [95].
As a further control experiment, a denaturing PAGE was performed to see if
Slu7/Prp18 catalyzes the second catalytic step at low and high salt concentrations.
The electrophoresis experiments showed that C complexes, in which Slu7/Prp18
has a low-anity binding site, were able to carry out the second catalytic step
after the addition of Prp16 and ATP (see g. 33). This indicates that Slu7/Prp18's
low-anity binding site on the C complex is its functionally relevant site.
Comparable FCCS experiments were performed with Prp16-eGFP. At 75 mM KCl,
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Prp16-eGFP had similar binding eciencies from B* to C*/PC complexes (see
g. 34). For the binding of Prp16-eGFP to the complexes at a salt concentration of
150 mM KCl, a dierent behavior was monitored. Prp16-eGFP was bound to the
B* complex but the binding to the C* complex was more ecient. In comparison to
the binding behavior of Slu7, the binding of Prp16 to the B* complex was stronger,
i.e. more salt-resistant because the cross-correlation amplitude for Prp16 to this
complex was still higher than for Slu7 even at high salt concentrations. The data
also indicated that Prp16 was still bound after the activation for the second step
catalysis and was destabilized from the spliceosome after the second catalytic step.
The measurements showed further that Prp16 is most stably bound to the C* com-
plex in which it is active. Several studies assumed a proofreading function for Prp16
because it can act during or before the rst catalytic step if the splicing reaction is
inuenced by mutations in the BS or the U6 snRNA [87] [97] [98] [69]. Using FCCS, it
was observed that Prp16 is bound to the early B* complex but is not required for
the rst catalytic step. This corresponds to Prp16's proofreading function.
As the FCCS measurements showed, binding sites are generated for the step 1 fac-
tor Cwc25 and the second step factors Slu7/Prp18 and Prp16 in the B* complex.
The measurements monitored further that the binding of Prp16 and Slu7/Prp18
to the B* complex are sensitive against increasing salt concentrations, but several
observations suggest that the binding is specic. The question arose whether Prp16
and Slu7 have partially overlapping or distinct binding sites on the B* complex.
Competition experiments performed with one labeled protein, e.g. Prp16-eGFP af-
ter addition of the same but unlabeled protein, i.e. Prp16, and after addition of
the other unlabeled protein, i.e. Slu7/Prp18, showed that Prp16's entry site on the
B* complex is distinct from Slu7/Prp18's entry site and they do not overlap (see
g. 35 and 36). Because Slu7/Prp18 bound with the same eciency to the B* and
C complex (which contains Cwc25), it was assumed that binding sites of Cwc25
and Slu7/Prp18 on the C complex do not overlap. Otherwise, the cross-correlation
amplitude for the C complex incubated with Slu7/Prp18 would have to decrease if
Cwc25 was bound to the complex. This was not observed and Cwc25 cannot be
dissociated from the spliceosome by competing for its binding site with Slu7/Prp18.
The advantage of binding sites for Prp16 and Slu7/Prp18 at the early stage of the
B* complex could be that the step 2 factors are already present in the spliceosome
before their catalytic function is needed during the second step.
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4.2.3 Model for the binding and activity of the step 1 and
step 2 splicing factors
Based on the ndings shown in this work on the dynamic behavior of spliceosomal
proteins to and from the spliceosome, the following model of substantial changes
from step 1 to step 2 catalysis can be made. The catalytic steps are shown schemat-
ically in gure 37.
Figure 37: Schematic representation of the binding and activity of step 1 and step 2
factors during the catalytic steps of the spliceosome. (Figure adapted from Ohrt et al. [84])
In the rst step, a high-anity binding site is generated for Cwc25 and low-anity
binding sites are generated for Slu7/Prp18 and Prp16 by the Prp2-mediated catalytic
activation of the Bact complex. After binding of the step 1 factor Cwc25, the rst
catalytic step proceeds. This leads to the formation of the C complex in which Cwc25
is stably bound. During this processes, a conformational change is likely to occur.
The low-anity binding site of Prp16 is transformed into a high-anity binding site
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which resists high salt concentrations of 150 mM KCl. Prp16 hydrolyzes ATP and
concomitantly the catalytic center is transformed from the step 1 into the step 2
conformation. The binding anity of Cwc25 is reduced due to the rearrangements
but is still bound. Due to Prp16's ATPase activity, the low-anity binding site for
Slu7/Prp18, which is also Slu7/Prp18's entry site, is transformed into a high-anity
one shown by the increased salt resistance of Slu7/Prp18's binding, and the ecient
docking of the 3'SS into the step 2 active site.
Most likely by the docking of the 3'SS into the active site, a conformational change
at the catalytic center is induced. This leads to the dissociation of Cwc25 and the
second catalytic step can occur. Prp16 is bound to the C* complex after hydrolyzing
ATP and dissociates when Slu7/Prp18 is stably bound to the complex.
Our results suggest that the step 2 factors and Cwc25 are bound simultaneously to
the catalytically activated spliceosome. The binding site of each factor is converted
or toggled from a low-anity, to a high-anity, and back to a low-anity site.
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5 Conclusion and outlook
Precise binding studies in highly complex macromolecular systems are challenging
to perform. In this thesis, FCCS was used to study the recruitment and dissociation
of certain proteins to the spliceosome.
An FCCS setup which allows for observing binding reactions, measuring low binding
constants, and distinguishing between binding sites of proteins in a complex was
implemented. A statement whether a protein has a low- or high-anity for a binding
site could be made. These applications make it possible to gain new insight in the
rearrangements during the catalytic steps of the spliceosome.
With FCCS, it could be shown that Cwc25 is bound with a high-anity to the
spliceosome after the Prp2-mediated rearrangements of the Bact complex into the
catalytically activated B* complex. By the activity of Prp16, local rearrangements
of the catalytic center from the step 1 to the step 2 conformation are induced. The
primary task of Slu7/Prp18 is then the docking of the 3'SS into the step 2 catalytic
center, which leads to the dissociation of Cwc25. It was shown that Slu7/Prp18 and
Prp16 bind early to distinct binding sites in the step 1-activated B* complex. One
important nding was that the low-anity binding sites of Prp16 and Slu7 were
converted into high-anity binding sites during spliceosomal maturation.
The results of the FCCS measurements provide information about the factor re-
quirement for the second catalytic step and the dynamics of step 1 and 2 factors
during the catalytic steps.
For future work, it would be interesting to investigate the recruitment and dissoci-
ation of other helicases, e.g. Prp22 and Prp43, to answer the questions: When are
these helicases recruited to the spliceosome? Which proteins or helicases induce the
recruitment or dissociation of Prp22 or Prp43? Is there an overlap between their
binding sites? All these questions can be again answered by FCCS and the estab-
lished experiments in this work. It would be interesting to determine the binding
constants for other proteins to gain comprehensive information about the regulation
of binding and dissociation of proteins in the spliceosome.
Another interesting aspect is the positioning of the step 1 and step 2 factors to each
other during the catalytic steps. With FCCS, information about the recruitment and
dissociation order of the splicing factors and their binding anities can be obtained
but not how the positions and orientations of the proteins within the spliceosome
change during the catalytic steps. Is the distance between Prp16 and Slu7/Prp18 al-
tering during the rearrangements? What is the distance between Cwc25 and Prp16?
86 5. Conclusion and outlook
One possibility to determine distances between certain proteins is given by Förster
Resonance Energy Transfer (FRET). This is a process which describes the energy
transfer between two uorophores. Through dipole-dipole coupling, a donor uo-
rphore in its electronically excited state may transfer energy to an acceptor uor-
phore. The eciency of the energy transfer is inversely proportional to the sixth
power of the distance between donor and acceptor. This makes FRET useful for
determining small distances between a molecule carrying the donor uorophore, e.g.
Prp16, and a molecule carrying the acceptor uorophore, e.g. Slu7/Prp18.
It would be interesting to determine changes in the distances of e.g. Prp2 and Spp2
from one stage of the splice cycle to another one. Other possible protein pairs are
Cwc22 and Cwc25, Snu114 and Cwc24, or Slu7/Prp18 and Prp16.
During the implementation of FRET for studies on the spliceosome, several aspects
have to be considered. First of all, suitable donor and acceptor uorophores have
to be chosen. The so-called Förster radius, i.e. the distance at which the energy
transfer eciency is 50 %, has to match the distances under investigation. With
standard FRET pairs, distances between 1-10 nm can be observed, which is the
distance range that would be expect in the catalytic center of the spliceosome.
Second, the orientation between both uorophores has to be considered. This is
taken into account by the orientation factor κ2, which depends of the relative orien-
tation of the donor's emission dipole moment and the acceptor's absorption dipole
moment. For freely rotating uorophores, κ2 adopts a value of 2/3. For the spliceo-
some, however, which is a complex system, the assumption of κ2 = 2/3 does not
hold. For such complex systems values for κ2 between 0 and 4 have to be assumed
depending on the orientation of the uorophores in the system. Until now it is not
possible to determine the orientation factor with experimental methods.
The distance between both uorophores depends on the Förster radius which in turn
depends on the orientation factor. It is important that the uorophores are attached
via a exible linker to the molecules of interest, since for freely rotating dyes, a
value of 2/3 can be assumed for the orientation factor and absolute distances can
be observed. Otherwise, only the relative movement of two molecules to each other
can be determined. When choosing uorescent dyes with the appropiate Förster
distance and orientations for the proteins of the spliceosome, the used FCCS setup
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